cephalosporin c has been researched along with Bacteremia in 430 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 117 (27.21) | 18.2507 |
| 2000's | 105 (24.42) | 29.6817 |
| 2010's | 164 (38.14) | 24.3611 |
| 2020's | 44 (10.23) | 2.80 |
| Authors | Studies |
|---|---|
| Barrera Pulido, L; Borreguero Borreguero, I; Bustos de Godoy, N; Camean-Fernández, M; Gutiérrez-Gutiérrez, B; León, MJ; López-Cerero, L; López-Cortés, LE; Marín-Candón, A; Merino, V; Pascual, A; Retamar, P; Rodriguez-Baño, J; Rosso-Fernández, CM; Salamanca, E | 1 |
| Dryden, M; Kantecki, M; Leister-Tebbe, H; Stone, GG; Wilcox, M; Yan, JL | 1 |
| Pitout, JDD | 1 |
| Kovacs, D; Matthews, L; Msanga, DR; Mshana, SE; Oravcova, K; Seni, J; Silago, V | 1 |
| Burd, EM; Davis, MH; Jacob, JT; Ozturk, T; Satola, SW; Steed, DB; Weiss, DS; Witt, LS | 1 |
| Badoordeen, GZ; Blakeway, LV; Byers, SMH; Cheng, AC; Cooper, BS; Cottingham, H; Hawkey, J; Jenney, AWJ; Lee, SJ; Loftus, MJ; Macesic, N; Naidu, R; Peleg, AY; Prasad, A; Prasad, V; Rafai, E; Stewardson, AJ; Tudravu, L; Vakatawa, T; van Gorp, E; Wati, S; Wisniewski, JA; Young-Sharma, TEMW | 1 |
| Maor, Y; Schwartz, O; Tocut, M; Yossepowitch, O; Zohar, I | 1 |
| Filgueira, A; Lima, O; Longueira-Suárez, R; Martinez-Lamas, L; Nodar, A; Pérez-Landeiro, A; Pérez-Rodríguez, MT; Portela-Pino, C; Rubianes, M; Sousa, A; Taboada-Martínez, C; Vasallo-Vidal, F | 1 |
| Karas, JA; Longshaw, CM; Santerre Henriksen, A; Slover, C; Yamano, Y | 1 |
| Ben-Zvi, H; Fanous, E; Herscovici, T; Kaplan, E; Livni, G; Mor, M; Schiller, O; Vardi, Y | 1 |
| Abbara, D; Afaneh, L; Al Duhailib, Z; Al Qahtani, MM; Al Sulaiman, K; Aldhayyan, N; Askar, G; Dyab, N; Hakeam, HA; Islami, M; Mansour, R | 1 |
| Burd, EM; Jacob, JT; Ozturk, T; Satola, SW; Weiss, DS; Witt, LS | 1 |
| Bruno, C; Dillon, RJ; Khankhel, ZS; Puzniak, L; Thosar, M | 1 |
| Mykietuk, A; Nannini, EC; Obed, MN; Toresani, I | 1 |
| Bakali, W; Bilima, S; Denis, B; Feasey, NA; Gordon, SB; Jewell, CP; Kawaza, K; Lalloo, DG; Langton, J; Lester, R; Mallewa, J; Mango, J; Mangochi, H; Musicha, P; Pearse, O | 1 |
| Blaine, BE; Kufel, WD; Mahapatra, R; Paolino, KM; Parsels, KA; Steele, JM; Thomas, SJ | 1 |
| Hata, A; Imoto, W; Ito, T; Kakeya, H; Kakuno, S; Katayama, T; Kawaguchi, H; Kobayashi, K; Nakaie, K; Nakatsuka, Y; Onoue, M; Sakurai, N; Shibata, W; Takahashi, T; Ueda, S; Uenoyama, K; Yamada, K | 1 |
| Bradley, J; Huynh, HK; Maher, JM; Mendes, RE; Porsch, EA; St Geme Iii, JW; Yagupsky, P | 1 |
| Gilboa, M; van Duin, D; Yahav, D | 1 |
| Annaert, P; Martins, FS; Martins, JES; Severino, P; Sy, SKB | 1 |
| Holmes, AH; Nasomsong, W; Panuvatvanich, B; Rawson, TM; Vasikasin, V | 1 |
| Bahrs, C; Bartonickova, L; Burgmann, H; Hagel, S; Paulussen, E; Pletz, MW; Schneider, L; Starzengruber, P; Tobudic, S | 1 |
| Cumper, C; Jones, M; Litherland, K; Richards, C; Smart, J | 1 |
| Campos, J; Diaz Högberg, L; Eckmanns, T; Giske, CG; Grundmann, H; Heuer, OE; Jarlier, V; Johnson, AP; Kahlmeter, G; Monen, J; Monnet, DL; Pantosti, A; Rossolini, GM; Simonsen, GS; van de Sande-Bruinsma, N; Vatopoulos, A; Żabicka, D; Žemličková, H | 1 |
| Karahan, ZC; Ozmen Capin, BB; Tekeli, A | 1 |
| Chambers, HF; Deresinski, S; Holubar, M; Kalil, AC | 1 |
| Drusano, G; Kaye, KS; Patel, T | 1 |
| Geriak, M; Haddad, F; Kullar, R; LaPlante, K; Nizet, V; Rose, W; Sakoulas, G; Zervos, M | 1 |
| Ballanti, S; Busca, A; Candoni, A; Cattaneo, C; Cefalo, M; Criscuolo, M; Daffini, R; Dargenio, M; Del Principe, MI; Delia, M; Dragonetti, G; Fanci, R; Giuliano, G; Laurino, M; Maracci, L; Marchesi, F; Nadali, G; Pagano, L; Simonetti, E; Spolzino, A; Trecarichi, EM; Tumbarello, M; Zannier, ME | 1 |
| Cheng, S; He, J; Jia, X; Liu, H; Ma, W; Tian, X; Zou, H | 1 |
| Bremell, D; Holmgren, A; Ljung, A | 1 |
| Bassetti, M; Cattelan, A; Giacobbe, DR; Mussini, C; Vena, A | 1 |
| Engelhardt, M; Fowler, VG; Hamed, K; Holland, TL; Jones, ME; Saulay, M; Seifert, H | 1 |
| Cuba, GT; da Costa, TM; Dos Santos, KRN; Kiffer, CRV; Morgado, PGM; Nicolau, DP; Nouér, SA | 1 |
| Shields, RK | 1 |
| Alosaimy, S; Lagnf, AM; Morrisette, T; Rybak, MJ | 1 |
| Abbate, R; Antonini, F; Cassir, N; Duclos, G; Hammad, E; Leone, M; Mathieu, C; Meresse, Z; Schouten, J; Zieleskiewicz, L | 1 |
| Bonten, MJM; Deelen, JWT; Giron Ortega, JA; Harbarth, S; Jacobsson, G; Rodriguez-Baño, J; Rottier, WC; Tacconelli, E; van Werkhoven, CH; Zahar, JR | 1 |
| Blyth, CC; Bowen, AC; Campbell, AJ; McMullan, BJ; McNeil, JC; Montgomery, CP; Tong, SYC | 1 |
| Alegria, W; Deresinski, S; Holubar, M; Meng, L | 1 |
| Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
| Clevenbergh, P; Dernier, Y; Grande Perez, C; Huang, TD; Kamgang, P; Maillart, E; Miendje Deyi, VY | 1 |
| Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O | 1 |
| Echols, R; Katsube, T; Kawaguchi, N; Wajima, T | 1 |
| Huang, M; Johnson, TM; Kiser, TH; Miller, MA; Molina, KC; Mueller, SW | 1 |
| Khan, S; Phe, K; Tam, VH | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Albert, E; Colomina, J; Costa, RM; Giménez, E; Huntley, D; Navarro, D; Olea, B; Oltra, R; Pascual, T; Pinto, C; Sánchez, D; Torres, I; Valdivia, A | 1 |
| Bourru, T; De Beauvoir, C; Gleize, M; Kyungu, V; Parmeland, L; Pecquet, M; Rousseau, N | 1 |
| Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
| Boka, K; Cortes, J; Lee, Y; Sagar, AS; Sandhu, U | 1 |
| Andersen, LP; Dzajic, E; Hammerum, AM; Hansen, DS; Hansen, F; Hasman, H; Justesen, US; Knudsen, JD; Roer, L; Røder, BL; Samulioniené, J; Schumacher, H; Stegger, M; Søndergaard, TS; Thomsen, MCF; Wang, M; Østergaard, C | 1 |
| Ishimaru, N; Kawamoto, M; Kinami, S; Ohnishi, H; Sakaguchi, A; Sakamoto, S; Takagi, A; Yoshimura, S | 1 |
| Kuti, JL; Miglis, C; Nicolau, DP; Rhodes, NJ; Scheetz, MH; Van Wart, SA | 1 |
| Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HS; Kim, SK; Lee, DG; Lee, JW; Park, BK | 1 |
| Chia, JH; Huang, CT; Lee, MH; Su, TY; Yang, CC; Ye, JJ | 1 |
| García, C; García, W; Gomes, C; Jacobs, J; Mateu, J; Ochoa, TJ; Palma, N; Pons, MJ; Riveros, M; Ruiz, J | 1 |
| Morisawa, Y; Sasahara, T; Suzuki, J; Toshima, M | 1 |
| Barreto, JN; Dierkhising, RA; Gangat, N; Mara, KC; Tosh, PK; Yemm, KE | 1 |
| Lasco, TM; Ledesma, KR; Skoglund, E; Tam, VH | 1 |
| Carratalà, J; Cuervo, G; Gudiol, C; Pujol, M; Shaw, E | 1 |
| Alkan, F; Apa, H; Bayram, N; Devrim, İ; Gözmen, S; Gülfidan, G; Ünal, N | 1 |
| Arena, F; Bassetti, M; D'Andrea, MM; Di Pilato, V; Giani, T; Henrici De Angelis, L; Pollini, S; Rossolini, GM | 1 |
| Butler, DF; Myers, AL | 1 |
| Beatson, SA; Ben Zakour, NL; Bhally, H; Crowe, A; Harris, PNA; Izharuddin, E; Jureen, R; Lee, TH; Looke, D; Lye, DC; Paterson, DL; Roberts, LW; Rogers, B; Runnegar, N; Schembri, MA; Tambyah, PA; Wailan, AM; Yin, M; Zowawi, HM | 1 |
| Cardozo, C; Cilloniz, C; De la Calle, C; Del Rio, A; García-Vidal, C; Marco, F; Martínez, JA; Mensa, J; Morata, L; Soriano, A; Ternavasio-de la Vega, HG; Torres, A | 1 |
| Arias, CA; Beganovic, M; LaPlante, KL; Luther, MK; Rice, LB; Rybak, MJ | 1 |
| Cortes-Penfield, N; Hunter, A; Oliver, NT; Rodriguez-Barradas, M | 1 |
| Ammerlaan, HSM; Bamberg, YRP; Bonten, MJM; Dorigo-Zetsma, JW; Kluytmans, JAJW; Kuck, EM; Prins, JM; Rottier, WC; Thijsen, SFT; van de Garde, EM; van der Linden, PD; van Hees, BC; van Werkhoven, CH; Verbon, A; Vlaminckx, BJM | 1 |
| Amzalag, J; Couzigou, C; Le Monnier, A; Mizrahi, A; Péan De Ponfilly, G; Pilmis, B | 1 |
| Chaves, F; Lora-Tamayo, J; Orellana, MÁ; Recio, R; Viedma, E; Villa, J | 1 |
| Hamed, K; Henriksen, AS; Smart, J | 1 |
| Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D | 1 |
| Bernards, AT; de Boer, MGJ; Lambregts, MMC; Visser, LG | 1 |
| Chen, SL; Heng, ST; Lye, DC; Ng, TM; Wong, JGX | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D | 1 |
| Bonten, MJM; Deelen, JWT; Rottier, WC; van Werkhoven, CH | 1 |
| Hsueh, PR; Hsueh, SC; Huang, YT; Lee, YJ; Liao, CH; Tsuji, M | 1 |
| Artioli, S; Bassetti, M; Capone, A; Carannante, N; Castaldo, N; Cattelan, A; Cipriani, L; Coletto, D; Digaetano, M; Grossi, P; Losito, AR; Mastroianni, CM; Menichetti, F; Mussini, C; Nicolè, S; Peghin, M; Righi, E; Russo, A; Tascini, C; Tumbarello, M; Vena, A | 1 |
| Bernards, ST; de Boer, MGJ; Hendriks, BJC; Lambregts, MMC; Visser, LG | 1 |
| Duncan, LR; Flamm, RK; Hamed, KA; Mendes, RE; Pfaller, MA; Sader, HS; Shortridge, D; Smart, JI | 1 |
| Chang, SC; Chen, YC; Huang, YS; Lin, WP; Wang, JT | 1 |
| Bhowmick, T; Boruchoff, SE; Imp, B; Liu, C; Sharma, R | 1 |
| Akova, M; Albasanz-Puig, A; Araos, R; Bote, A; Brunel, AS; Calik, S; Carratalà, J; Del Pozo, JL; Drgona, L; García, E; Gomes, MZR; Gudiol, C; Hemmati, P; Herrera, F; Ibrahim, KY; Isler, B; Kanj, S; Kern, W; Maestro de la Calle, G; Manzur, A; Marin, JI; Márquez-Gómez, I; Martín-Dávila, P; Mikulska, M; Montejo, JM; Montero, M; Morales, HMP; Morales, I; Novo, A; Oltolini, C; Parody, R; Peghin, M; Puerta-Alcalde, P; Ruiz-Camps, I; Sipahi, OR; Tebe, C; Tilley, R; Yáñez, L | 1 |
| Agnelli, F; Baratta, F; Colombo, F; Frantellizzi, V; Pani, A; Pastori, D; Scaglione, F | 1 |
| Hurley, JC | 1 |
| Barberán, J; Llinares, P; Mensa, J | 1 |
| Morata, L; Soriano, A | 1 |
| Bidet, P; Bingen, E; Cohen, R; D'humières, C; Mariani-Kurkdjian, P; Sobral, E | 1 |
| Blackburn, R; Hope, R; Johnson, AP; Livermore, DM; Reynolds, R; Woodford, N | 1 |
| Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HK; Lee, DG; Lee, JW | 1 |
| Hashiguchi, R; Komatsu, M; Matsuyama, S; Moronaga, Y; Nagahara, C; Oshiro, Y; Sameshima, I; Takeyama, H; Tottori, N; Yaita, K; Yamaguchi, Y | 1 |
| Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW | 1 |
| Aitken, SL; Altshuler, J; Arias, CA; Esaian, D; Guervil, D; Papadopoulos, J | 1 |
| Cha, MK; Chung, DR; Kang, CI; Kim, SH; Ko, KS; Lee, NY; Peck, KR; Song, JH; Wi, YM | 1 |
| Pleiman, CM; Polenakovik, HM | 1 |
| Chia, JH; Hsu, PC; Lee, MH; Su, TY; Wu, HF; Ye, JJ | 1 |
| Boucher, BA; Croce, MA; Fabian, TC; Ponnapula, S; Swanson, JM; Wells, DL; Wood, GC | 1 |
| Bai, C; Chen, Y; Li, D; Zhang, P; Zhang, Q; Zhang, W; Zheng, S | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Chan, CY; Jacob-Kokura, S; Kaplan, L | 1 |
| Alves, MD; Behle, TF; De Bacco, G; Luz, DI; Mattiello, F; Pasqualotto, AC; Ribeiro, VB; Tessari, JP; Vieira, FJ; Zavascki, AP | 1 |
| Batard, E; Corvec, S; Hardouin, JB; Montassier, E; Potel, G | 1 |
| Fuglsang-Damgaard, D; Hammerum, AM; Hansen, F; Heltberg, O; Justesen, US; Knudsen, JD; Olsen, SS | 1 |
| Bae, IK; Cho, YK; Hwang, SS; Jeong, SH; Kim, J; Kim, JM; Lee, K; Park, YS; Seo, YH | 1 |
| Eckburg, PB; Friedland, HD; Jandourek, A; Llorens, L; Smith, A; Thye, DA | 1 |
| Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH | 1 |
| Baghdady, N; Ferraro, MJ; Galar, A; Guzmán-Suarez, BB; Hooper, DC; Kubiak, DW; Marty, FM; O'Brien, TF; Siedner, MJ | 1 |
| Avutu, V; Cao, X; Flynn, PM; Gaur, AH; Hayden, RT; Howard, SC; Inaba, H; Marszal, LN; Pounds, SB; Pui, CH; Ribeiro, RC; Rubnitz, JE | 1 |
| Almirante, B; Miró, JM; Pericás, JM | 1 |
| Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M | 1 |
| Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H | 1 |
| Bressler, AM; Casapao, AM; Dhand, A; Ebright, JR; Goff, DA; Johns, S; Kaatz, GW; Kullar, R; Lee, Y; Moise, PA; Nizet, V; Nonejuie, P; Okumura, CY; Olson, J; Pogliano, J; Rose, WE; Rybak, MJ; Sakoulas, G | 1 |
| Axelrod, P; Gallagher, JC; Haynes, K; Kuriakose, S | 1 |
| Chan, MC; Chang, FY; Lee, Y; Lin, JC; Lin, TY; Yang, YS; Yeh, KM | 1 |
| Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, K; Ko, JH; Lee, NY; Lee, WJ; Peck, KR; Song, JH; Yoo, JR | 1 |
| Barber, KE; Rybak, MJ; Sakoulas, G | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Adelman, MH; Bader, J; Crane, JK; Jacobs, DM; Paladino, JA; Schentag, JJ; Shields, RK; Taylor, J; Wilton, GJ | 1 |
| Apiranthiti, KN; Falagas, ME; Vardakas, KZ | 1 |
| Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Jung, SW; Kang, JH; Kim, HK; Lee, DG; Lee, JW; Park, YJ | 1 |
| Espedido, BA; Jensen, SO; van Hal, SJ | 1 |
| Cao, JM; Gan, TE; Ji, CH; Lv, B; Wu, JN; Wu, YH; Zhu, YX | 1 |
| Duffy, A; Gilmore, S; Heil, EL; Nguyen, AD; Patel, NK | 1 |
| Berhin, C; Bogaerts, P; De Smet, B; Glupczynski, Y; Huang, TD; Jacobs, JA; Peetermans, WE; Phe, T; Vlieghe, ER | 1 |
| Abdallah, DI; Estaitieh, N; Ibrahim, A; Jisr, T; Moghnieh, R; Mugharbil, A; Sinno, L; Ziade, F | 1 |
| Choi, JY; Chong, Y; Chung, HS; Kim, JM; Ku, NS; Lee, K; Yong, D | 1 |
| Liu, J; McLaughlin, MM; Qi, C; Rhodes, NJ; Scheetz, MH | 1 |
| Baxi, SM; Chan, D; Jain, V | 1 |
| Mahfood Haddad, T; Sundaragiri, PR; Vallabhajosyula, S; Vivekanandan, R | 1 |
| Benosman, H; Epelboin, L; Geffrier, C; Jarlier, V; Lemaitre, N; Poynard, T; Renvoisé, A; Saintenoy, G; Thabut, D | 1 |
| Rolston, K | 1 |
| Alkatib, S; Chalana, IK; Chaudhry, K; Chopra, T; Johnson, PC; Kaye, KS; Marchaim, D; Mohammed, M; Pogue, JM; Tamam, Z; Tansek, R; Zhao, JJ | 1 |
| Abbott, AN; Werth, BJ | 1 |
| Ahmed, S; Ali, SA; Arsalan, A; Naqvi, SB; Shakeel, O | 1 |
| Cordonnier, C; Doghmi, K; El Maaroufi, H; Goubard, A; Legrand, P; Maury, S; Mikdame, M; Pautas, C; Redjoul, R; Schwarzinger, M; Toma, A | 1 |
| Doi, S; Fujita, N; Hayashi, A; Ichiyama, S; Komori, T; Matsumura, Y; Nagao, M; Shimizu, T; Takakura, S; Tanaka, M; Watanabe, H; Yamamoto, M | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Ramasamy, C | 1 |
| Bensekhri, H; Compain, F; Lavollay, M; Mainardi, JL; Rostane, H | 1 |
| Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF | 1 |
| Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
| Faragher, EB; Feasey, NA; Gordon, MA; Heyderman, RS; Jassi, C; MacLennan, CA; Mallewa, J; Mallewa, M; Masesa, C; Msefula, C | 1 |
| Chang, EK; Huang, YT; Kao, KL; Liao, CH; Liu, CY; Tsai, MS; Yang, CJ | 1 |
| Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
| Jalava, J; Kärki, T; Lyytikäinen, O; Martelius, T; Möttönen, T; Ollgren, J | 1 |
| Chung, SJ; Kwa, AL; Lim, TP | 1 |
| Barker, BR; Mosher, CA; Owen, JL | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Afifi, IK; Elgamasy, MA; Hagag, AA; Hassan, SM | 1 |
| Honda, T; Horiuchi, K; Kasuga, E; Matsumoto, T; Natori, T; Negishi, T; Saito, S; Sugano, M; Takehara, K | 1 |
| Jiang, Y; Kuang, L; Li, L; Li, M; Wang, H; Zhou, W | 1 |
| Gustinetti, G; Mikulska, M | 1 |
| Horikoshi, Y; Kawamura, Y; Miyata, I; Tomida, J; Toyofuku, M; Yuza, Y | 1 |
| Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S | 1 |
| Deresinski, S; Holubar, M; Meng, L | 1 |
| Aitken, SL; Bhatti, MM; DePombo, AM; Gettys, SC; Kontoyiannis, DP; Nicolau, DP; Nunez, CA; Tverdek, FP | 1 |
| Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
| Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
| Cao, Y; Chen, XJ; Chen, YP; Du, LZ; Hua, CZ; Hua, ZY; Jing, CM; Li, XL; Lin, ZL; Lu, HP; Luo, QE; Wang, CQ; Xu, HM; Yu, H; Yu, HM; Zhang, H; Zhang, T; Zhuang, JQ | 1 |
| Burnett, YJ; Echevarria, K; Traugott, KA | 1 |
| Addison, NO; Awuah-Mensah, G; Labi, AK; Labi, JE; Obeng-Nkrumah, N | 1 |
| Algora-Weber, A; de la Calle-Pedrosa, N; Delgado-Iribarren, A; Gabán-Díez, Á; González-Jiménez, AI; Hernández-Tejedor, A; Martín-Vivas, A; Merino-Vega, CD; Ruiz de Luna-González, R; Temprano-Gómez, I | 1 |
| Bamford, C; Buys, H; Eley, B; Muloiwa, R | 1 |
| Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Lee, NY | 1 |
| Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Tang, HJ; Wang, JL | 1 |
| Casapao, AM; Claeys, KC; Davis, SL; Klinker, KP; Lagnf, AM; Rybak, MJ; Sabagha, N; Trinh, TD; Zasowski, EJ | 1 |
| Cho, HL; Hung, MC; Hung, SC; Lai, MC; Lee, YC; Wang, HP; Wang, JT | 1 |
| Altshuler, J; Fedorenko, M; Gritsenko, D; Ruhe, JJ | 1 |
| Fernandez, J; Nanjappa, S; Pabbathi, S; Srikumar, T | 1 |
| Gentry, CA; Ratliff, AR; Williams, RJ | 1 |
| Arshad, S; Hartman, P; Huang, V; Moreno, D; Perri, MB; Zervos, MJ | 1 |
| Barber, KE; Stover, KR; White, BP | 1 |
| Diaz-Martinez, LA; Ramirez-Blanco, CE; Ramirez-Rivero, CE; Sosa-Avila, LM | 1 |
| Balada-Llasat, JM; Bauer, KA; Bremmer, DN; Goff, DA | 1 |
| Blunt, MC; Liebowitz, LD | 1 |
| Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F | 1 |
| Chen, YH; Liu, ZY; Wu, R; Yao, WZ; Zhang, XW; Zhou, QT | 1 |
| Cheong, HS; Chung, DR; Jung, CW; Kang, CI; Ko, KS; Peck, KR; Song, JH; Wi, YM | 1 |
| Ge, Y; Janes, R; Morrissey, I | 1 |
| Deal, EN; Micek, ST; Reichley, RM; Ritchie, DJ | 1 |
| Martínez-Lamas, L; Romero-Jung, PA; Treviño, M; Varón, C | 1 |
| Amicosante, G; Falcone, M; Mancini, C; Mezzatesta, ML; Perilli, M; Stefani, S; Venditti, M | 1 |
| Douvoyiannis, M; Kalyoussef, S; Mayers, MM; Philip, G | 1 |
| Heckeroth, A; Leendertse, I; Rohdich, N; Thomas, E; Wilhelm, C; Zschiesche, E | 1 |
| Chang, EP; Chen, TL; Chiang, DH; Lin, ML; Liu, CY; Wang, FD | 1 |
| Otuk, G; Ozbek, B | 1 |
| Choe, KW; Jang, HC; Jeon, JH; Kim, EC; Kim, HB; Kim, NJ; Lee, S; Oh, MD; Park, SW; Park, WB; Song, KH | 1 |
| Chung, DR; Joung, MK; Kang, CI; Ko, KS; Lee, JA; Moon, SY; Peck, KR; Song, JH | 1 |
| Chong, Y; Ito, Y; Kamimura, T; Yakushiji, H | 1 |
| Gastmeier, P; Meyer, E; Schroeren-Boersch, B; Schwab, F | 1 |
| Bacigalupo, A; Boni, L; Cappellano, P; Del Bono, V; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Prinapori, R; Raiola, AM; Van Lint, MT; Viscoli, C | 1 |
| Branger, C; Clermont, O; Courpon-Claudinon, A; Denamur, E; Dornic, Q; Fantin, B; Lefort, A; Mentré, F; Panhard, X; Wolff, M | 1 |
| Aoki, Y; Fukuoka, M; Magarifuchi, H; Nagasawa, Z; Nagata, M; Urakami, T | 1 |
| Argyropoulou, A; Berger, J; Bompola, M; Borg, M; Davey, PG; de Kraker, ME; Dumpis, U; Ghita, MC; Grabljevec, S; Grundmann, H; Horvatic, J; Icket, C; Kaasch, A; Kalenic, S; Koller, W; Kolman, J; Lansbury, L; Melbarde Kelmere, A; Nagler, J; Noble, M; Paniara, O; Raglio, A; Seifert, H; Skally, M; Smyth, E; Turner, D; Wolkewitz, M; Xuereb, D | 1 |
| Bonnedahl, J; Brudin, L; Hedebäck, F; Jarnheimer, PÅ; Sandelin, LL; Schön, T; Wistedt, A | 1 |
| Caldera, J; Calvo, A; Figuera, M; Gómez, M; Guevara, RN; Khalil, R; Landaeta, ME; Morón, M; Nuñez, MJ; Palavecino, S; Redondo, MC; Ríos, H; Rivera, R; Vitelli, J | 1 |
| Al-Hasan, MN; Baddour, LM; Eckel-Passow, JE | 1 |
| Chen, TY; Lee, YT; Liu, KS; Teng, YH; Tsao, SM; Tsui, TL; Wang, YL | 1 |
| Heide, CV; Hornecker, E; Mausberg, RF; Nusime, A; Ziebolz, D | 1 |
| Bäcker, M; Chotikanatis, K; Hammerschlag, MR; Rosas-Garcia, G | 1 |
| Kallio, MJ; Kallio, P; Pääkkönen, M; Peltola, H | 1 |
| Cadena, J; Childs, LM; Gonzalez-Velez, M; Ho, TT; Lewis, JS | 1 |
| Freeman, JT; Gamble, GD; Holland, DJ; McBride, SJ; Nisbet, MS; Taylor, SL; Williamson, DA | 1 |
| Cheong, HS; Chung, DR; Kang, CI; Ko, KS; Peck, KR; Song, JH | 1 |
| Green, K; Hughes, DW; Lewis, JS; Maxwell, PR; Perez, KK | 1 |
| Alangaden, G; Bernabela, L; Bhargava, A; Chaudhry, K; Chen, TY; Chopra, T; Ellsworth, J; Hatahet, D; Johnson, P; Kaye, KS; Marchaim, D; Pogue, JM; Rahbar, H; Rodriguez, V; Tansek, R; Truong, T; Veltman, J; Yousuf, A; Zhao, JJ | 1 |
| Daniels, TL; O'Neal, CS; O'Neal, HR; Talbot, TR | 1 |
| Aung, G; Fierer, J; Jahng, M; Johns, S; Lin, JC; Thomas, A | 1 |
| Chen, CH; Chen, JB; Chuang, FR; Lee, CH; Lee, CT; Li, SH; Wu, CH; Yang, CC | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H | 1 |
| Bonomo, RA; Droz, S; Endimiani, A; Hilty, M; Hujer, AM; Mühlemann, K; Perreten, V; Seiffert, SN; Sendi, P | 1 |
| Eckburg, PB; Friedland, HD; Kollef, M; Llorens, L; Shorr, AF | 1 |
| Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H | 1 |
| Kim, BN; Kim, YS; Ryu, J; Woo, JH | 2 |
| Benetucci, A; Campos, AL; Famiglietti, A; Melero, MJ; Vay, CA | 1 |
| Kim, BN; Kim, MN; Kim, YS; Lee, SO; Ryu, J; Woo, JH | 1 |
| Rothstein, JP | 1 |
| Choi, SH; Choo, EJ; Chung, JW; Kim, BN; Kim, MN; Kim, NJ; Kim, TH; Kim, YS; Ryu, J; Woo, JH | 1 |
| Matsuda, H; Miwa, H; Miyazaki, S; Tsuji, M | 1 |
| Kurosaki, T | 1 |
| Oishi, K | 1 |
| Chu, SH; Hsu, RB; Tsay, YG; Wang, SS | 1 |
| Blijlevens, N; de Pauw, B; Donnelly, P; Levenga, H; Shirango, H; Verweij, P | 1 |
| Akyüz, C; Büyükpamukçu, M; Ceyhan, M; Kanra, G; Kurne, O; Kutluk, T; Seçmeer, G | 1 |
| Hasbun, R; Mushatt, D; Myers, L; Ruhe, JJ | 1 |
| Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
| Chevalier, I; Gauthier, M; Tapiero, B | 1 |
| Chiu, CH; Chiu, S; Lin, TY | 1 |
| Akiyama, N; Imajo, K; Masaoka, T; Ohyashiki, K; Suzuki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
| Lee, CH; Liu, JW; Tang, YF | 1 |
| Evans, RB; Halbur, PG; Kinyon, JM; Pallarés, FJ; Roth, JA; Schmitt, CS | 1 |
| Glück, T | 1 |
| Calabuig, E; Cervera, JI; Sauquillo, JM; Todolí, JA | 1 |
| Martin, DR; Plouffe, JF | 1 |
| Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Lee, KD; Oh, MD; Park, WB | 1 |
| de Ciman, R; Gross, U; Zimmermann, O | 1 |
| Bell, LM; Bilker, WB; Chu, JH; Coffin, SE; Goyal, M; Lautenbach, E; McGowan, KL; Nachamkin, I; Zaoutis, TE | 1 |
| Ansart, S; Garre, M; Le Berre, R; Lerch, C; Nicolas, X; Pennec, YL; Tandé, D | 1 |
| Hanson, ND; Jorgensen, JH; Lewis, JS; Moland, ES; Song, W; Thomson, KS | 1 |
| Cal, RG; Castelo, A; do Carmo Filho, JR; Marra, AR; Pereira, CA; Sader, HS; Wey, SB | 1 |
| Ambrose, PG; Ramphal, R | 1 |
| Bhalla, P; Manchanda, V; Sethi, M; Sharma, VK | 1 |
| Attias, D; Henshke-Bar-Meir, R; Raveh, D; Rudensky, B; Schlesinger, Y; Yinnon, AM | 1 |
| Brincat, M; Saunders, W; Savarrio, L | 1 |
| Bin, C; Hui, W; Minjun, C; Renyuan, Z; Xiuli, X; Yingchun, X; Yongzhong, N; Yuanjue, Z | 1 |
| Lee, CH; Liu, JW; Su, LH; Tang, YF | 1 |
| Dahal, RK; Khadga, PK; Koirala, J; Mishra, SK; Pokharel, BM; Tuladhar, NR | 1 |
| Bang, JW; Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, NJ; Kim, SH; Oh, MD | 1 |
| Hsueh, PR; Jean, SS; Wang, JY | 1 |
| de Cueto, M; Hernández, JR; Muniain, MA; Navarro, MD; Pascual, A; Ríos, MJ; Rodríguez-Baño, J; Romero, L | 1 |
| Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK | 1 |
| Ellis-Pegler, R; Palmer, S; Ritchie, S | 1 |
| Deal, EN; Dunne, WM; Kollef, MH; Micek, ST; Reichley, RM; Ritchie, DJ | 1 |
| Morelle, AM; Zavascki, AP | 1 |
| Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
| Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA | 1 |
| Grigg, AP; Roberts, AW; Sainani, A; Schwarer, AP; Slavin, MA; Spencer, A; Szer, J; Thursky, KA | 1 |
| Chang, SC; Chen, SC; Chen, SY; Chen, TH; Chen, WJ; Chen, YC; Chiang, WC; Chien, KL; Lee, CC; Su, CP; Wu, GH; Yen, AM | 1 |
| Blot, SI; Decruyenaere, JM; Depuydt, PO; Vandijck, DM | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Chang, LY; Chiu, CH; Huang, YC; Lin, PY; Lin, TY; Tsai, MH; Yen, MH | 1 |
| Bhat, SV; Capitano, B; Lodise, TP; Paterson, DL; Peleg, AY; Potoski, BA; Shutt, KA | 1 |
| Chung, HJ; Kim, MN; Ko, SY; Sung, HS | 1 |
| Andreu, L; Cañizares, R; Cuadrado, JM; de la Tabla, VO; Jover, F; Martin, C; Martínez, S; Merino, J; Roig, P | 1 |
| McKinnon, PS; Paladino, JA; Schentag, JJ | 1 |
| Brown, M; Chee, L; Grigg, AP; MacGregor, L; Sasadeusz, J | 1 |
| Conil, JM; Cougot, P; Decun, JF; Dieye, E; Georges, B; Houin, G; Lavit, M; Saivin, S; Samii, K; Seguin, T | 1 |
| Jadoul, M; Labriola, L | 1 |
| Dorvaux, V; Guerci, AP; Lederlin, P; Paitel, JF | 1 |
| Garibaldi, JA; Nguyen, TT | 2 |
| Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
| Grasmug, E; Hammer, HF; Hoefler, G; Reisinger, EC; Stauber, RE; Trauner, M | 1 |
| Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
| Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
| Boswell, TC; Nye, KJ; Smith, EG | 1 |
| Kelly, JW; McAllister, CK; Schrank, JH | 1 |
| Lesher, JL; Rabb, DC | 1 |
| de Meyer, A; Lauwers, S; Piérard, D | 1 |
| Chow, JW; Salacata, A | 1 |
| Arstila, T; Auvinen, H; Huovinen, P | 1 |
| Daum, RS; Leitch, CD; Nachman, JP; Tenover, FC | 1 |
| Giamarellou, H | 1 |
| Albanese, J; Domart, Y; Durbec, O; Gouin, F; Grès, JJ; Leroy, J; Martin, C; Papazian, L; Rollin, C; Veyssier, P | 1 |
| Clark, CD; Dunagan, WC; Picus, D | 1 |
| Gwanzura, L; Kowo, H; Mason, PR; Mubaiwa, L; Nathoo, KJ | 1 |
| Geddes, AM; Norrby, SR | 1 |
| Ariza, J; Gudiol, F; Martin, R; Pallares, R; Peña, C; Pujol, M | 1 |
| Goto, S; Miyazaki, S; Toyosawa, T; Tsuji, A; Yamaguchi, K | 1 |
| Almquist, JR; Colina, KF; Nizet, V; Rubens, CE; Smith, AL | 1 |
| Eda, S; Fujimoto, K; Hachiya, T; Honda, T; Kobayashi, T; Kubo, K; Morita, M; Sato, E; Sekiguchi, M | 1 |
| Champion, MP; Marsh, MJ; Murdoch, IA; Sajjanhar, T | 1 |
| Hollis, DG; Jordan, J; Lindquist, SW; Mangum, ME; Weber, DJ | 1 |
| Chesney, PJ; Davis, Y; English, BK; Wang, WC | 1 |
| Ishii, Y; Miyazaki, S; Ohno, A; Tsuji, M; Yamaguchi, K | 1 |
| Bizette, GA; Bradford, HB; Cole, JT; Kemmerly, SA; Peltier, BH | 1 |
| Dupont, MJ; Estavoyer, JM; Guibourdenche, M; Kirchgesner, V; Michel-Briand, Y; Plesiat, P; Riou, JY | 1 |
| Chiu, CT; Lien, JM; Lin, CJ; Lin, DY; Sheen, IS | 1 |
| Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
| Ishibashi, K; Ogihara, M; Shigeta, S; Shiraiwa, Y; Yamaguchi, O | 1 |
| Furuya, N; Hirakata, Y; Matsumoto, T; Tateda, K; Yamaguchi, K | 1 |
| Cisterna, R; Farga, MA; Garau, J; García-de-Lomas, J; Gimeno, C; Millás, E; Navarro, D; Savall, F | 1 |
| Aquino, VM; Buchanan, GR; Mustafa, MM; Pappo, A; Tkaczewski, I | 1 |
| Childs, S; Geckler, R; Sharifi, R | 1 |
| Cuenca Estrella, M; Esteban Moreno, J; Nuñez García, A; Ramos Rincón, JM | 1 |
| Langman, G | 1 |
| López, MM; Martín, C; Merino, J; Navarro, V; Roig, PP; Sánchez, B; Zorraquino, A | 1 |
| Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL | 1 |
| Liam, CK; Parasakthi, N; Riley, PA | 1 |
| Kullberg, BJ; Meis, JF; van der Ven, AJ; Vandamme, P | 1 |
| Byl, B; Jacobs, F; Struelens, MJ; Thys, JP | 1 |
| Rothman, AL; Spaulding, AC | 1 |
| Shah, PM | 1 |
| Dankert, J; Kamps, WA; Muis, N | 1 |
| Hashemi, FN; Hayden, MK; Matushek, MG; Miyashiro, D; Quinn, JP; Schiappa, DA; Smith, KY; Sullivan, J; Trenholme, GM; Weinstein, RA | 1 |
| Krause, I; Nimri, R | 1 |
| Abumustafa, F; Cunha, BA; Domenico, P; Imambaccus, H; Qadri, SM; Tullo, DD; Ueno, Y | 1 |
| Geletko, SM; Melbourne, KM; Mikolich, DJ | 1 |
| Cherchi, GB; Chiesa, C; Cossellu, S; Fadda, G; Gallisai, D; Pacifico, L; Ranucci, A; Zanetti, S | 1 |
| Cutts, E; Lepow, M; Swanson, H | 1 |
| Dajani, AS; Jacobs, RF; Kaplan, SL; Leggiadro, RJ; Puri, SK; Rim, CS; Schutze, GE | 1 |
| Bjökholm, M; Engervall, P; Günther, G; Hast, R; Kalin, M; Ljungman, P; Lönnqvist, B; Ringertz, S; Stiernstedt, G | 1 |
| Gonzales, J; Overturf, GD; Shandler, L | 1 |
| Chang, SC; Chen, YC; Hsieh, WC; Luh, KT; Shih, CC | 1 |
| Culver, D; Danzing, L; Edwards, J; Gaynes, R; Stroud, L | 1 |
| Hall, G; Heimdahl, A; Nord, CE | 1 |
| Deshpande, AK; Kaundinya, DV; Shah, SS | 1 |
| Chen, YS; Cheng, DL; Liu, YC; Wang, JH; Wann, SR; Yen, MY | 1 |
| Berchtold, W; Hauser, R; Schreiber, A | 1 |
| Bucklin, SE; Morrison, DC | 1 |
| Kobayashi, I; Nohara, T | 1 |
| Costanzo, MR; Fischer, SA; Piccione, W; Trenholme, GM | 1 |
| Cordonnier, C; Delain, M; Delmer, A; Gardembas, M; Gres, JJ; Herbrecht, R; Ladeb, S; Moreau, P; Nalet, V; Pico, JL; Rollin, C | 1 |
| Bourlinou, PK; Karachalios, GN; Nasiopoulou, DD; Reppa, A | 1 |
| Garcia, R; Raad, I | 1 |
| alMohsen, I; English, BK; Luedtke, G | 1 |
| Browne, GJ; McIntyre, P; Ryan, JM | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Hitt, CM; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Lal, HM; Mathur, NC; Mathur, YC | 1 |
| Balkissoon, AR; Jolles, PR; Pinson, AG | 1 |
| Eiberg, J; Jørgensen, J; Levi, N; Prag, J; Schroeder, TV; Skov Jensen, J | 1 |
| Bryant, AE; Stevens, DL | 1 |
| Medeiros, AA | 1 |
| Hungerford, DS; Mont, MA; Waldman, BJ | 1 |
| Fraser, V; Kollef, MH; Murphy, D; Pasque, C; Sharpless, L; Vlasnik, J | 1 |
| El-Guizaoui, AE; Watanakunakorn, C | 1 |
| Demitrovicová, A; Grausova, S; Grey, E; Koren, P; Kralóvicová, K; Krcméry, V; Krupova, I; Kukucková, E; Kunová, A; Lacka, J; Oravcová, E; Pichna, P; Spanik, S; Svec, J; Trupl, J | 1 |
| Barquet, N; Casado-Flores, J; Domingo, P; Osona, B | 1 |
| Jones, RN; Marshall, SA; Pfaller, MA | 1 |
| Brown, SP; Buckingham, SC; Joaquin, VH | 1 |
| Chiodo, F; Ferri, M; Manfredi, R; Nanetti, A | 1 |
| Behre, G; Hiddemann, W; Link, H; Maschmeyer, G; Meyer, P; Paaz, U; Wilhelm, M | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Rosón, B | 1 |
| Antony, B; Kumari, PG; Rao, PL; Shivananda, PG | 1 |
| Haszard, D | 1 |
| Escande, MC; Herbrecht, R | 1 |
| Lyons, CJ; Marshman, WE | 1 |
| Wilson, WR | 1 |
| Feintzeig, ID; Fogel, MA; Gavin, JP; Hunt, WA; Kim, RC; Nussbaum, PB | 1 |
| Claudel, P; Clyti, E; Gautier, C; Geniaux, M | 1 |
| Chang, TC; Ko, WC; Wu, HM; Wu, JJ; Yan, JJ | 1 |
| Geddes, AM; Norrby, SR; Shah, PM | 1 |
| Biedenbach, DJ; Doern, GV; Jones, RN; Marshall, SA; Pfaller, MA | 1 |
| Chang, SC; Chen, YC; Fang, CT; Hsieh, SM; Hsueh, PR; Hung, CC; Liu, CJ; Sheng, WH | 1 |
| Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
| Bachur, R; Harper, MB; Silverstein, M | 1 |
| Abe, T; Fukuda, M; Hirashima, K; Karasawa, M; Miura, Y; Moriyama, Y; Motoyoshi, K; Nagata, N; Naruse, T; Ninomiya, H; Oh, H; Saito, K; Shibata, A; Shishido, H; Yoshida, M | 1 |
| Inamatsu, T | 1 |
| Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R | 1 |
| Andrieu, P; Archambaud, M; Chabanon, G; Cougot, P; Decun, JF; Georges, B; Houin, G; Mazerolles, M; Saivin, S; Suc, C; Virenque, C | 1 |
| Bekale, J; Kombila, M; Okome-Kouakou, M | 1 |
| Simmons, WP | 1 |
| Aswapokee, N; Bowonwatanuwong, C; Chayakul, P; Chetchotisakd, P; Dusitnanond, V; Kulpradist, SA; Leelasupasri, S; Rajanuwong, A; Suttinont, C; Suwangool, P | 1 |
| Bukhari, RH; Lohr, JM; Paget, DS; Roberts, WH; Welling, RE; Zayyat, EJ | 1 |
| Dormann, AJ; Grünewald, T; Huchzermeyer, H; Kleimann, F; Kloppenborg, A; Risius, H; Wigginghaus, B | 1 |
| Edwards, MS; Noyola, DE | 1 |
| Baptist, EC; Louthain, L | 1 |
| Coffin, SE; Ruth, A; Shah, SS | 1 |
| Lim, TK; Stebbings, AE | 1 |
| Lim, JK; Yap, KB | 1 |
| Rybkin, AK; Shliapnikov, SA | 1 |
| Erdem, G; Schleiss, MR | 1 |
| Angus, BJ; Chaowagul, W; Prins, JM; Simpson, AJ; Smith, MD; Suputtamongkol, Y; van Deventer, SJ; Weverling, GJ; White, NJ | 1 |
| Bernier, C; Bouvard, E; Meyniel, D; Parrot, A; Saidi, F | 1 |
| Abdullah, WA; Arasu, A; Ariffin, H; Lee, CL; Mohamed, M; Navaratnam, P; Peng, LH | 1 |
| Kolpak, S; Mehler, PS | 1 |
| Al-Tawfiq, JA; Cushing, HE; Sarosi, GA | 1 |
| Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D | 1 |
| De Arriba, JJ; Escribano, E; Fernández, JM; Ferreras, P; Sánchez, MV; Serrano, M | 1 |
| Chuang, YC; Ko, WC; Lee, HC; Liu, CC; Wu, JJ | 1 |
| Wong, EB | 1 |
| Guttigoli, A; Zaman, MM | 1 |
| Angus, BJ; Chaowagul, W; Mattie, H; Smith, MD; Suputtamongkol, Y; Walsh, AL; White, NJ; Wuthiekanun, V | 1 |
| Lee, WS; Parasakthi, N; Puthucheary, SD | 1 |
| Boulétreau, P; Mohammedi, I; Vieille, E | 1 |
| Auten, R; Benjamin, DK; Fisher, RG; McKinney, RE; Ross, K | 1 |
| Lumbiganon, P; Panamonta, O | 1 |
| Guichenez, G; Guichenez, P; Joomaye, Z; Marciano, J; Oziol, E; Ygout, JY | 1 |
| Alcaide, F; Carratalà, J; Fernández-Sevilla, A; Gudiol, F; Marron, A | 1 |
| Desai, N; Hill, RL; Philpott-Howard, J; Shannon, K; Verma, A | 1 |
| Hohmann, EL | 1 |
| Heiss, M; Kern, WV; Steinbach, G | 1 |
| Phantumchinda, K; Suankratay, C; Tachawiboonsak, W; Wilde, H | 1 |
| Ahcan, J; Arnez, M; Pleterski-Rigler, D; Radsel-Medvescek, A; Ruzić-Sabljić, E; Strle, F | 1 |
| Becerril, B; Caballero-Granado, FJ; Cisneros, JM; Cuberos, L; Moreno, I; Pachón, J | 1 |
| Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
| Babela, R; Gould, IM; Jurga, L; Krcméry, V; Kunova, A; Mateicka, F; Novotny, J; Pichnova, E; Sabo, A; Sykora, P; Trupl, J | 1 |
| Barson, WJ; Bradley, JS; Givner, LB; Kaplan, SL; Kim, KS; Mason, EO; Schutze, GE; Tan, TQ; Wald, ER; Yogev, R | 1 |
| Bonomo, RA; Casellas, JM; Klugman, KP; Ko, WC; McCormack, JG; Mulazimoglu, L; Paterson, DL; Rice, LB; Von Gottberg, A; Yu, VL | 1 |
| Carmeli, Y; Cosgrove, S; Eliopoulos, GM; Harris, A; Kaye, KS | 1 |
| Clair, A; Golledge, CL; Harvey, J; Inglis, TJ | 1 |
| Morrison, DC; Opal, SM; Palardy, JE; Parejo, N | 1 |
| Wall, RA | 1 |
| Bigham, M; Daly, P; Davies, D; Dobson, S; Husain, E | 1 |
| Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y | 1 |
| Bush, K; Hindler, J; Lee, N; Loeloff, M; Pegues, DA; Queenan, AM; Quinn, JP; Wong-Beringer, A | 1 |
| Al-Aqeeli, AA; Al-Jumaah, SA; Guy, ML | 1 |
| Andrieu, P; Archambaud, M; Bonnet, E; Chabanon, G; Chaminade, B; Conil, JM; Cougot, P; Decun, JF; Georges, B; Houin, G; Roche, C; Saivin, S; Samii, K; Virenque, C | 1 |
| Chen, YS; Fung, CP; Liu, CY; Wong, WW; Yu, KW | 1 |
| Beloborodov, VB | 1 |
| Coulaud, JP; Detruchis, P; Jaccard, A; Karam-Sarkis, D; Leport, C; Meyohas, MC; Rosenbaum, W; Salmon-Ceron, D; Vildé, JL | 1 |
| Alpegiani, M; Andreini, BP; Del Nero, S; Della Bruna, C; Franceschi, G; Jabés, D; Perrone, E; Rossi, R; Visentin, G; Zarini, F | 1 |
| Baquero, F; Canton, R; Gomez-Alferez, A; Loza, E; Martinez-Beltran, J | 1 |
44 review(s) available for cephalosporin c and Bacteremia
| Article | Year |
|---|---|
Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
Topics: Adult; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Humans; Pneumonia; Soft Tissue Infections; Treatment Outcome | 2022 |
Ceftolozane/tazobactam for the treatment of bacteremia: a systematic literature review (SLR).
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Communicable Diseases; Humans; Tazobactam | 2022 |
Clinical Management of
Topics: Adolescent; Age Factors; Algorithms; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Child; Child, Preschool; Delphi Technique; Drug Administration Schedule; Echocardiography; Endocarditis, Bacterial; Glycopeptides; Humans; Incidence; Infant; Infant, Newborn; Injections, Intravenous; Methicillin-Resistant Staphylococcus aureus; Observational Studies as Topic; Penicillins; Randomized Controlled Trials as Topic; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2020 |
Peripherally inserted central catheter-related bloodstream infection due to Tsukamurella pulmonis: a case report and literature review.
Topics: Acquired Immunodeficiency Syndrome; Actinobacteria; Administration, Intravenous; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Catheter-Related Infections; Catheterization, Peripheral; Cefozopran; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2017 |
Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Fosfomycin; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Penicillins; Staphylococcal Infections; Staphylococcus aureus | 2017 |
Changing Epidemiology of Haemophilus influenzae in Children.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Female; Haemophilus Infections; Haemophilus influenzae type b; Humans; Incidence; Infant; Male; Meningitis, Bacterial; Pneumonia; Post-Exposure Prophylaxis; Rifampin; Vaccination | 2018 |
A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin-Resistant Enterococci | 2018 |
Off-label use of ceftaroline fosamil: A systematic review.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Endocarditis, Bacterial; Healthcare-Associated Pneumonia; Humans; Meningitis; Off-Label Use | 2019 |
Ceftobripole: Experience in staphylococcal bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Daptomycin; Drug Therapy, Combination; Humans; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2019 |
Liver abscess caused by multidrug-resistant Pseudomonas aeruginosa treated with colistin; a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cholangitis; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Kidney; Liver Abscess, Pyogenic; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Outcome; Young Adult | 2013 |
[Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis].
Topics: Animals; Bacteremia; Ceftaroline; Cephalosporins; Clinical Trials as Topic; Disease Models, Animal; Endocarditis, Bacterial; Humans; Staphylococcal Infections | 2014 |
Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Humans; Methicillin; Odds Ratio; Penicillins; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.
Topics: Aged, 80 and over; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2015 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
Bloodstream infections in neutropenic cancer patients: A practical update.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Disease Management; Drug Resistance, Bacterial; Febrile Neutropenia; Fluoroquinolones; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pre-Exposure Prophylaxis; Risk Factors | 2016 |
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin | 2016 |
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Salvage Therapy; Staphylococcal Infections | 2016 |
Salmonella enterica subspecies arizonae infection of adult patients in Southern Taiwan: a case series in a non-endemic area and literature review.
Topics: Aged; Ampicillin; Bacteremia; Cephalosporins; Female; Hospital Mortality; Humans; Male; Middle Aged; Retrospective Studies; Salmonella arizonae; Salmonella Infections; Taiwan; Treatment Outcome | 2016 |
Ceftaroline for the treatment of methicillin-resistant
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Treatment Outcome | 2017 |
[Haemophilus influenzae infection].
Topics: Bacteremia; Cephalosporins; Diagnosis, Differential; Drug Resistance, Bacterial; Drug Therapy, Combination; Haemophilus Infections; Haemophilus influenzae; Humans; Meningitis, Bacterial; Penicillins; Prognosis; Respiratory Tract Infections; Serotyping | 2003 |
[Pseudomonas aeruginosa infection].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections | 2003 |
Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger?
Topics: Actinomycetales; Actinomycetales Infections; Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Translocation; Cefepime; Cephalosporins; Clostridium Infections; Colistin; Cytarabine; Daunorubicin; Drug Therapy, Combination; Etoposide; Fatal Outcome; Hemoptysis; Humans; Hydroxyurea; Immunocompromised Host; Intestinal Mucosa; Leukemia, Myeloid, Acute; Male; Metronidazole; Middle Aged; Neutropenia; Pneumonia, Bacterial; Superinfection; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Macrolides; Pneumonia, Pneumococcal | 2004 |
[Bacteremia and pneumonia due to Yersinia enterocolitica serotype O:3 in an immunocompetent patient].
Topics: Aged; Bacteremia; Cephalosporins; Drug Therapy, Combination; France; Humans; Immunocompetence; Male; Pneumonia, Bacterial; Serotyping; Trimethoprim, Sulfamethoxazole Drug Combination; Yersinia enterocolitica; Yersinia Infections | 2005 |
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Treatment Outcome | 2006 |
Endodontics and infective endocarditis--is antimicrobial chemoprophylaxis required?
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Endocarditis, Bacterial; Humans; Practice Guidelines as Topic; Pulpotomy; Risk Factors; Root Canal Therapy | 2006 |
Bacteremia caused by Salmonella enterica serotype Choleraesuis in Taiwan.
Topics: Aneurysm, Infected; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Biological Evolution; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fever; Fluoroquinolones; Humans; Plasmids; Prevalence; Salmonella enterica; Salmonella Infections; Species Specificity; Swine; Taiwan; Virulence; Virulence Factors | 2006 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Cephalosporin therapeutics for intensive care infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Severity of Illness Index; Tissue Distribution; Treatment Outcome | 1993 |
The position of recently developed broad-spectrum cephem antibiotics in bacterial septicemia.
Topics: Bacteremia; Bacteria; Bacterial Infections; Cefepime; Cefpirome; Cephalosporins; Clinical Trials as Topic; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 1996 |
Streamlining antimicrobial therapy for lower respiratory tract infections.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Catheterization; Cephalosporins; Drug Therapy; Fluoroquinolones; Hospitalization; Humans; Macrolides; Patient Satisfaction; Phlebitis; Respiratory Tract Infections | 1997 |
Pneumococcal sacroiliitis.
Topics: Administration, Oral; Adult; Arthritis, Infectious; Bacteremia; Buttocks; Ceftriaxone; Cephalosporins; Consciousness; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Pain; Penicillin G; Penicillins; Pneumococcal Infections; Sacroiliac Joint; Streptococcus pneumoniae; Thigh | 1997 |
Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Alcaligenes; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Female; HIV-1; Humans; Male; Respiratory Tract Infections | 1997 |
The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients.
Topics: Bacteremia; Cephalosporins; Cross Infection; Humans; Severity of Illness Index; Treatment Outcome | 1998 |
[Sepsis by Escherichia coli].
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Diagnosis, Differential; Escherichia coli; Escherichia coli Infections; Humans | 1999 |
Infection due to Moraxella osloensis: case report and review of the literature.
Topics: Bacteremia; Cephalosporins; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Male; Moraxella; Neisseriaceae Infections | 2000 |
Pyomyositis in the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Drainage; Follow-Up Studies; HIV Infections; Humans; Leukocytosis; Male; Muscle, Skeletal; Muscular Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Bacteremic cellulitis caused by Non-01, Non-0139 Vibrio cholerae: report of a case in a patient with hemochromatosis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cellulitis; Cephalosporins; Doxycycline; Hemochromatosis; Humans; Male; Treatment Outcome; Vibrio cholerae | 2000 |
Nontyphoidal salmonellosis.
Topics: Anti-Infective Agents; Bacteremia; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Focal Infection; Food Microbiology; Gastroenteritis; HIV Infections; Humans; Immunocompromised Host; Salmonella; Salmonella Infections | 2001 |
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Cephalosporins; Child; Female; Genotype; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2001 |
Meningococcal disease--some issues in treatment.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillins; Steroids; Time Factors; Treatment Outcome | 2001 |
[A choice of antibacterial chemotherapy for nosocomial infections caused by pathogens producing broad-spectrum beta-lactamases].
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cross Infection; Humans | 2001 |
43 trial(s) available for cephalosporin c and Bacteremia
| Article | Year |
|---|---|
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant
Topics: Bacteremia; Cephalosporins; Clinical Trials, Phase III as Topic; Enterobacteriaceae; Humans; Meropenem; Multicenter Studies as Topic; Penicillins; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic | 2021 |
Which trial do we need? How to treat Pseudomonas aeruginosa bacteraemia-proposal for an umbrella randomized controlled trial.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections | 2023 |
Ceftobiprole versus daptomycin in
Topics: Adult; Bacteremia; Cephalosporins; Clinical Trials as Topic; Daptomycin; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure; Treatment Outcome; Young Adult | 2020 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Female; Hospitals; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome | 2017 |
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 2014 |
Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.
Topics: Adult; Aged; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Hospital Departments; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Citrobacter freundii; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2009 |
Clindamycin vs. first-generation cephalosporins for acute osteoarticular infections of childhood--a prospective quasi-randomized controlled trial.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clindamycin; Female; Finland; Humans; Infant; Infusions, Intravenous; Male; Osteoarthritis; Osteomyelitis; Prospective Studies; Staphylococcus aureus; Treatment Outcome | 2012 |
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Pneumonia, Pneumococcal; Retrospective Studies; Treatment Outcome | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins | 2013 |
Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Empiricism; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Meropenem; Neoplasms; Neutropenia; Therapeutic Equivalency; Thienamycins; Treatment Outcome | 2004 |
Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Topics: Amikacin; Antineoplastic Agents; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Immunocompromised Host; Japan; Leukemia; Male; Neutropenia; Opportunistic Infections | 2004 |
Evaluation of a ceftiofur-washed whole cell Streptococcus suis bacterin in pigs.
Topics: Animals; Bacteremia; Bacterial Vaccines; Cephalosporins; Specific Pathogen-Free Organisms; Streptococcal Infections; Streptococcus suis; Swine; Swine Diseases | 2004 |
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Species Specificity; Treatment Outcome | 2006 |
A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Male; Neutropenia; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2007 |
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
Topics: Aged; Anti-Bacterial Agents; APACHE; Area Under Curve; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Endpoint Determination; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Predictive Value of Tests; Pseudomonas aeruginosa; Renal Insufficiency; Sepsis; Treatment Outcome | 2008 |
Cefepime in intensive care unit patients: validation of a population pharmacokinetic approach and influence of covariables.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Creatinine; Cross Infection; France; Humans; Infusions, Intravenous; Intensive Care Units; Metabolic Clearance Rate; Middle Aged; Models, Biological; Nonlinear Dynamics; Prospective Studies | 2008 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia.
Topics: Aged; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Drug Eruptions; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Safety | 1995 |
Low-dosage cefepime as treatment for serious bacterial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacteria; Bacterial Infections; Cefepime; Cephalosporins; Female; Freeze Drying; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Powders; Respiratory Tract Infections; Skin Diseases, Infectious; Therapeutic Equivalency; Urinary Tract Infections | 1993 |
A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Bacterial Infections; Cefepime; Cephalosporins; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Male; Middle Aged; Respiratory Tract Infections; Shock, Septic | 1993 |
Efficacy of cefpirome in the treatment of septicaemia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; Cefpirome; Cephalosporins; Double-Blind Method; Humans; Microbial Sensitivity Tests; Single-Blind Method | 1993 |
Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections.
Topics: Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Female; Humans; Male; Middle Aged; Time Factors; United States; Urinary Tract Infections | 1996 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance | 1996 |
Trimethoprim-sulfamethoxazole plus amikacin versus ceftazidime monotherapy as empirical treatment in patients with neutropenia and fever.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Blood; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Middle Aged; Neutropenia; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.
Topics: Adult; Aged; Bacteremia; Cefaclor; Cephalosporins; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tooth Extraction | 1996 |
Cefoperazone monotherapy for serious infections in hospitalized patients--an initial Indian experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefoperazone; Cephalosporins; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; India; Injections, Intravenous; Male; Middle Aged; Treatment Outcome | 1995 |
Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gastrointestinal Diseases; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Male; Neutropenia; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 1997 |
Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial.
Topics: Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Cholangitis; Cholecystitis; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Ofloxacin; Phlebitis | 1996 |
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Meropenem; Middle Aged; Neutropenia; Thienamycins | 1998 |
Randomized comparative trial of cefpirome versus ceftazidime in the empirical treatment of suspected bacteraemia or sepsis. Multicentre Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cefpirome; Ceftazidime; Cephalosporins; Female; Humans; Male; Middle Aged; Sepsis | 1998 |
Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment.
Topics: Asian People; Bacteremia; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Humans; Pneumonia, Bacterial; Taiwan; Urinary Tract Infections | 1998 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Drug Therapy, Combination; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Lenograstim; Leukocyte Count; Male; Middle Aged; Neutropenia; Pneumonia; Recombinant Proteins; Tobramycin; Treatment Outcome | 1999 |
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin | 1999 |
[Continuous versus intermittent cefepime infusion in critical care. Preliminary results].
Topics: Bacteremia; Cefepime; Cephalosporins; Critical Care; Drug Administration Schedule; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged | 1999 |
Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefpirome; Cephalosporins; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome | 1999 |
A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications.
Topics: Aged; Antibiotic Prophylaxis; Bacteremia; Ceftriaxone; Cephalosporins; Drug Costs; Economics, Pharmaceutical; Enteral Nutrition; Erythema; Exudates and Transudates; Female; Follow-Up Studies; Gastroscopy; Gastrostomy; Humans; Male; Neoplasms; Nervous System Diseases; Pneumonia; Prospective Studies; Sepsis; Suppuration; Surgical Wound Infection | 1999 |
[The role of cefepime, a 4th-generation cephalosporin, in treating patients with surgical sepsis].
Topics: Adolescent; Adult; Aged; Bacteremia; Cefepime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Middle Aged; Severity of Illness Index; Surgical Wound Infection; Systemic Inflammatory Response Syndrome | 1999 |
Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Biomarkers; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Cytokines; Female; Humans; Imipenem; Interleukin-10; Interleukin-6; Lactates; Logistic Models; Male; Melioidosis; Middle Aged; Prognosis; Thienamycins; Tumor Necrosis Factor-alpha | 2000 |
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.
Topics: Adult; Aged; Bacteremia; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Female; Humans; Infusions, Intravenous; Linear Models; Male; Melioidosis; Middle Aged; Models, Biological; Statistics, Nonparametric | 2000 |
[Importance of a cefpirome-vancomycin combination on bactericidal kinetics in severe MRSA infections in intensive care].
Topics: Adult; Aged; Bacteremia; Cefpirome; Cephalosporins; Critical Care; Drug Therapy, Combination; Female; Humans; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2002 |
343 other study(ies) available for cephalosporin c and Bacteremia
| Article | Year |
|---|---|
Population Dynamics of Escherichia coli Causing Bloodstream Infections over Extended Time Periods.
Topics: Anti-Bacterial Agents; Bacteremia; Canada; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; England; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Population Dynamics | 2021 |
The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Cephalosporins; Delivery of Health Care; Escherichia coli; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Sepsis; Tanzania | 2022 |
Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
Topics: Bacteremia; Cephalosporins; Cross Infection; Fiji; Humans; Length of Stay; Prospective Studies | 2022 |
Short- and long-term mortality in patients with urosepsis caused by Escherichia coli susceptible and resistant to 3rd generation cephalosporins.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2022 |
Ceftazidime-avibactam treatment in bacteremia caused by OXA-48 carbapenemase-producing Klebsiella pneumoniae.
Topics: Adult; Aged; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
Comment on: Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
Definitive antibiotic treatment with a third-generation cephalosporin and with piperacillin-tazobactam worked well for some children with Serratia bacteraemia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Female; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Serratia; Thrombocytopenia | 2022 |
Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam | 2022 |
'Bacteraemia with an MBL-producing Klebsiella pneumoniae: treatment and the potential role of cefiderocol heteroresistance'-authors' response.
Topics: Bacteremia; Cefiderocol; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2022 |
Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Escherichia coli; Humans; Malawi; Morbidity; Prospective Studies; Sepsis | 2022 |
Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Humans; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2023 |
The Clinical Evaluation of Third-generation Cephalosporins As Definitive Therapy for Enterobacter spp. and Klebsiella aerogenes Bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Enterobacter; Enterobacter aerogenes; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
In vitro Activity of Ceftaroline Against an International Collection of Kingella kingae Isolates Recovered From Carriers and Invasive Infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ceftaroline; Cephalosporins; Child; Child, Preschool; Endocarditis; Humans; Kingella kingae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests | 2023 |
Physiologically based pharmacokinetic modelling to inform combination dosing regimens of ceftaroline and daptomycin in special populations.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Child; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation cephalosporin-resistant Enterobacterales bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Ertapenem; Escherichia coli; Humans; Propensity Score; Prospective Studies; Shock, Septic | 2023 |
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Escherichia coli; Escherichia coli Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quinolones; Retrospective Studies; Sulbactam | 2023 |
Efficacy of ceftobiprole in a murine model of bacteremia and disseminated infection.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Disease Models, Animal; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Europe; European Union; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance | 2019 |
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin | 2020 |
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care | 2019 |
Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"
Topics: Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Standard of Care; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hematologic Neoplasms; Humans; Infection Control; Italy; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Prospective Studies; Risk Factors | 2019 |
Heteroresistance to cefepime in Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; China; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Research Design; Retrospective Studies; Risk Factors | 2020 |
Clinical Efficacy of Ceftolozane-Tazobactam Versus Other Active Agents for the Treatment of Bacteremia and Nosocomial Pneumonia due to Drug-Resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Healthcare-Associated Pneumonia; Humans; Pharmaceutical Preparations; Polymyxins; Pseudomonas aeruginosa; Tazobactam; Treatment Outcome | 2020 |
Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
Topics: Anti-Bacterial Agents; Bacteremia; Brazil; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Monte Carlo Method; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
Topics: Adolescent; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamases; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Osteomyelitis; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Siderophores | 2020 |
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Cohort Studies; Daptomycin; Drug Therapy, Combination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome | 2020 |
Decreased duration of intravenous cephalosporins in intensive care unit patients with selective digestive decontamination: a retrospective before-and-after study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Administration Schedule; Female; France; Gastrointestinal Tract; Hospitals, University; Humans; Infusions, Intravenous; Intensive Care Units; Male; Retrospective Studies | 2020 |
An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Humans; Prospective Studies; Sepsis | 2021 |
Compassionate use of cefiderocol in a pancreatic abscess and emergence of resistance.
Topics: Abscess; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cefiderocol; Cephalosporins; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Male; Middle Aged; Pancreatitis; Pseudomonas aeruginosa; Staphylococcus aureus; Treatment Outcome | 2021 |
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam | 2020 |
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
Topics: Anti-Bacterial Agents; Bacteremia; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Pneumonia; Sepsis; Siderophores; Urinary Tract Infections | 2021 |
Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Synergism; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Salvage Therapy; Standard of Care; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2021 |
Real life experience with ceftolozane/tazobactam therapy for
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Cephalosporins; Comorbidity; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Tazobactam | 2021 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
Performance of a MALDI-TOF mass spectrometry-based method for rapid detection of third-generation oxymino-cephalosporin-resistant Escherichia coli and Klebsiella spp. from blood cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunoassay; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2021 |
A rapid and inexpensive protocol to screen for third generation cephalosporin-resistant and non-fermenting Gram-negative rods directly in positive blood cultures.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Blood Culture; Cephalosporin Resistance; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Oxidoreductases; Prospective Studies; Sensitivity and Specificity | 2021 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
Antimicrobial salvage therapy for native valve MRSA endocarditis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Daptomycin; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction | 2017 |
[Retropharyngeal abscess with cervical discitis and vertebral osteomyelitis caused by Escherichia coli in a patient with liver cirrhosis].
Topics: Aged; Airway Obstruction; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cervical Vertebrae; Discitis; Disease Susceptibility; Drainage; Drug Substitution; Escherichia coli Infections; Humans; Liver Cirrhosis, Alcoholic; Magnetic Resonance Imaging; Male; Neck Pain; Osteomyelitis; Oxygen Inhalation Therapy; Retropharyngeal Abscess; Tomography, X-Ray Computed | 2017 |
Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia: a 'Goldilocks' window.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Serum; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2017 |
Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Topics: Adolescent; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Fever; Fluoroquinolones; Humans; Male; Meropenem; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2017 |
Resistance to quinolones, cephalosporins and macrolides in Escherichia coli causing bacteraemia in Peruvian children.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Macrolides; Methionine Sulfoxide Reductases; Microbial Sensitivity Tests; Mutation; Quinolones | 2017 |
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult | 2018 |
Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Bacterial; Humans; Immunocompromised Host; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2017 |
Risk factors for bacteremia with extended-spectrum β-lactamase production in positive Escherichia coli bacteremia in a pediatric setting.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Length of Stay; Male; Pediatrics; Retrospective Studies; Risk Factors; Software; Turkey | 2017 |
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Italy; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Whole Genome Sequencing | 2018 |
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Topics: Aged; Aged, 80 and over; Australia; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Male; Middle Aged; Multilocus Sequence Typing; New Zealand; Phylogeny; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Singapore; Whole Genome Sequencing | 2018 |
Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Macrolides; Male; Middle Aged; Pneumonia, Pneumococcal; Propensity Score; Prospective Studies | 2018 |
Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections | 2018 |
Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2018 |
Clinical impact of rapid bacterial identification by MALDI-TOF MS combined with the bêta-LACTA™ test on early antibiotic adaptation by an antimicrobial stewardship team in bloodstream infections.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Bacteria; beta-Lactamases; Blood Culture; Cephalosporin Resistance; Cephalosporins; Humans; Microbial Sensitivity Tests; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2018 |
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; beta-Lactamases; Ceftazidime; Cephalosporins; Clone Cells; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Survival Analysis; Tazobactam | 2018 |
Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015.
Topics: Anti-Infective Agents; Bacteremia; Cephalosporins; Drug Resistance, Bacterial; Epidemiological Monitoring; Humans; Ireland; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; United Kingdom | 2018 |
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane-
Topics: Anti-Infective Agents; Bacteremia; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States | 2018 |
Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al.
Topics: Bacteremia; Case-Control Studies; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Female; Genes, Bacterial; Humans; Klebsiella pneumoniae; Male; Mutation; Phylogeny; Virulence; Virulence Factors | 2018 |
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors | 2018 |
'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' - Author's reply.
Topics: Bacteremia; Case-Control Studies; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Taiwan; Tazobactam | 2019 |
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Cephalosporins; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Skin Diseases, Bacterial; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2019 |
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Cohort Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2019 |
Ceftobiprole activity when tested against contemporary bacteria causing bloodstream infections in the United States (2016-2017).
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; United States | 2019 |
Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Prevalence; Risk Factors | 2019 |
Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; New Jersey; Salvage Therapy; Staphylococcal Infections; Treatment Failure | 2019 |
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; International Cooperation; Logistic Models; Multicenter Studies as Topic; Neoplasms; Neutropenia; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Retrospective Studies; Tazobactam; Time Factors | 2019 |
Studies of selective digestive decontamination as a natural experiment to evaluate topical antibiotic prophylaxis and cephalosporin use as population-level risk factors for enterococcal bacteraemia among ICU patients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cross Infection; Decontamination; Enterococcus; Gastrointestinal Tract; Humans; Incidence; Intensive Care Units; Oropharynx; Respiration, Artificial; Risk Factors | 2019 |
Introduction.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Pneumonia, Bacterial; Pseudomonas; Staphylococcal Infections; Staphylococcus aureus | 2019 |
In vitro interaction between cefepime and amoxicillin-clavulanate against extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male | 2013 |
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Prescriptions; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; United Kingdom | 2013 |
Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Streptococcal Infections; Viridans Streptococci | 2013 |
Reply to Altshuler et al.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, too.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
Topics: Aging; Bacteremia; beta-Lactamases; Biliary Tract Diseases; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Retrospective Studies; Urinary Tract Infections | 2013 |
Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Analysis | 2015 |
Treatment of Rhizobium radiobacter bacteremia in a critically ill trauma patient.
Topics: Adult; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Critical Illness; Female; Humans; Opportunistic Infections; Treatment Outcome; Wounds and Injuries | 2013 |
Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neoplasms; Prevalence; Retrospective Studies; Risk Factors | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Bacteremia and empyema caused by Shewanella algae in a trauma patient.
Topics: Adult; Bacteremia; Cephalosporins; Empyema, Pleural; Gram-Negative Bacterial Infections; Humans; Lung Injury; Male; Shewanella; Wounds, Gunshot | 2014 |
Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Substitution; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome | 2014 |
Use of fluoroquinolones and third-generation cephalosporins in the emergency department: an 11-year survey.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Emergency Service, Hospital; Fluoroquinolones; France; Health Care Surveys; Humans; Incidence; Respiratory Tract Infections; Urinary Tract Infections | 2014 |
Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Denmark; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals; Humans; Isoenzymes; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids | 2014 |
Risk factors and molecular epidemiology of community-onset extended-spectrum β-lactamase-producing Escherichia coli bacteremia.
Topics: Age Factors; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Community-Acquired Infections; Decision Making, Computer-Assisted; Escherichia coli; Escherichia coli Infections; Humans; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Tertiary Care Centers; Urinary Tract Infections | 2014 |
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure | 2014 |
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2014 |
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Candidiasis; Cefepime; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Ciprofloxacin; Consolidation Chemotherapy; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Incidence; Induction Chemotherapy; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Neoplasm Staging; Nose; Outpatients; Rectum; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2014 |
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins | 2014 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Health; Cephalosporins; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Hospitalization; Hospitals, Teaching; Hospitals, Urban; Humans; Institutionalization; Long-Term Care; Middle Aged; Nalidixic Acid; Ofloxacin; Pyelonephritis; Retrospective Studies; Risk Factors | 2014 |
Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteremia; Cathelicidins; Ceftaroline; Cephalosporins; Daptomycin; Drug Therapy, Combination; Female; Humans; Male; Mice; Middle Aged; Salvage Therapy; Staphylococcal Infections; Staphylococcus | 2014 |
Case-case-control study of patients with carbapenem-resistant and third-generation-cephalosporin-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2014 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Taiwan | 2015 |
Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study.
Topics: Adult; Anti-Bacterial Agents; Bacillus; Bacteremia; Case-Control Studies; Central Venous Catheters; Cephalosporins; Female; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Republic of Korea; Risk Factors | 2015 |
Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ceftaroline; Cephalosporins; Demography; Disease Eradication; Female; Glycopeptides; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Time Factors; Treatment Failure; Vancomycin | 2014 |
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Child; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2015 |
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Drug Tolerance; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Salvage Therapy; Staphylococcal Infections; Vancomycin | 2015 |
Epidemiology and microbiology of nosocomial bloodstream infections: analysis of 482 cases from a retrospective surveillance study.
Topics: Acinetobacter; Adult; Aged; Aged, 80 and over; Bacteremia; Cephalosporins; China; Coagulase; Cross Infection; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Medicine, Chinese Traditional; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors; Shock, Septic; Staphylococcus; Treatment Outcome | 2015 |
A single-center evaluation of the risk for colonization or bacteremia with piperacillin-tazobactam- and cefepime-resistant bacteria in patients with acute leukemia receiving fluoroquinolone prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Leukemia; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Post-Exposure Prophylaxis; Random Allocation; Retrospective Studies; Risk Factors; Young Adult | 2016 |
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cambodia; Cefotaxime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Prevalence; Prospective Studies; Sequence Analysis, DNA; Young Adult | 2015 |
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation w
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lebanon; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Young Adult | 2015 |
Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections; Young Adult | 2015 |
Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome | 2015 |
Mycotic pseudoaneurysm by vancomycin-intermediate Staphylococcus aureus: a rare cause of persistent bacteraemia.
Topics: Aneurysm, False; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Debridement; Diagnosis, Differential; Drug Resistance, Microbial; Femoral Artery; Humans; Ligation; Male; Middle Aged; Mycoses; Staphylococcus aureus; Thigh; Vancomycin; Venous Thrombosis | 2015 |
Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Bacteremia; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Liver Transplantation; Male; Middle Aged; Treatment Outcome; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2015 |
Regarding: Ko JH, et al.: Clinical features and risk factors for development of Bacillus bacteremia among adult patients with cancer: a case-control study. Supp Care Cancer 2015;23(2):377-84.
Topics: Bacillus; Bacteremia; Cephalosporins; Female; Humans; Male; Neoplasms | 2015 |
Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Case-Control Studies; Cefepime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Michigan; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Microbial Viability | 2015 |
In vitro bactericidal activity of cefepime and cefpirome against clinical isolates at Karachi.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pakistan; Proteus; Proteus Infections; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 2015 |
Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia.
Topics: Aged; Bacteremia; beta-Lactamases; Cefmetazole; Cephalosporins; Escherichia coli; Female; Humans; Male; Middle Aged | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Bacteremia; beta-Lactam Resistance; Case-Control Studies; Catheter-Related Infections; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Phylogeny; Recurrence; Retrospective Studies; Risk Factors | 2015 |
Dentist-Urologist Interplay in the Dental Management of Penile Prosthesis Patient.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Dental Care; Dentists; Humans; Male; Patient Care Team; Penile Prosthesis; Physicians; Prosthesis-Related Infections; Urology | 2015 |
β LACTA test for rapid detection of Enterobacteriaceae resistant to third-generation cephalosporins from positive blood cultures using briefly incubated solid medium cultures.
Topics: Bacteremia; Bacteriological Techniques; beta-Lactam Resistance; Blood; Cephalosporins; Chromogenic Compounds; Culture Media; Enterobacteriaceae; Humans; Prospective Studies; Reagent Kits, Diagnostic; Time Factors | 2015 |
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Three Epidemics of Invasive Multidrug-Resistant Salmonella Bloodstream Infection in Blantyre, Malawi, 1998-2014.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Epidemics; Epidemiological Monitoring; Female; Fluoroquinolones; Humans; Incidence; Infant; Infant, Newborn; Malawi; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Salmonella enterica; Salmonella enteritidis; Salmonella Infections; Salmonella typhi; Salmonella typhimurium; Serotyping; Young Adult | 2015 |
Occult Klebsiella pneumoniae bacteremia at emergency department: A single center experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Asymptomatic Diseases; Bacteremia; Cephalosporins; Clavulanic Acid; Emergency Service, Hospital; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Patient Discharge; Retrospective Studies; Taiwan | 2015 |
Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Finland; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Prospective Studies | 2016 |
Intravenous ceftaroline 200 mg administered every 8 h is safe and adequate for meticillin-resistant Staphylococcus aureus bloodstream infections in end-stage renal failure patients on haemodialysis: a case study.
Topics: Administration, Intravenous; Aged; Bacteremia; Ceftaroline; Cephalosporins; Discitis; Drug Administration Schedule; Endocarditis; Humans; Kidney Failure, Chronic; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcal Infections | 2015 |
Staphylococcus aureus Bacteremia Masquerading as Leukocytoclastic Vasculitis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Biopsy, Needle; Cephalosporins; Complement C3; Diagnosis, Differential; Echocardiography; Erythema; Fluorescent Antibody Technique; Humans; Hypotension; Immunoglobulin A; Immunoglobulin G; Male; Purpura; Staphylococcal Infections; Staphylococcus aureus; Tachycardia; Vasculitis, Leukocytoclastic, Cutaneous | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Blood Cell Count; Candida; Cefepime; Cephalosporins; Child; Child, Preschool; Egypt; Febrile Neutropenia; Female; Fungi; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Male; Pharynx; Pseudomonas aeruginosa; Staphylococcus aureus | 2016 |
Catheter-Related Bacteremia Due to Gordonia sputi in a Patient with Acute Lymphocytic Leukemia: a Case Report.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Bacteremia; Blood Culture; Catheter-Related Infections; Cefozopran; Cephalosporins; Gordonia Bacterium; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Ribosomal, 16S | 2016 |
The Clinical Characteristics of Neonatal Sepsis Infection in Southwest China.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia.
Topics: Adult; Agammaglobulinemia; Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cellulitis; Cephalosporin Resistance; Cephalosporins; Genetic Diseases, X-Linked; Helicobacter; Helicobacter Infections; Humans; Immunocompromised Host; Immunoglobulins; Leg; Male; Microbial Sensitivity Tests; Penicillin Resistance; Treatment Failure; Young Adult | 2016 |
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome | 2016 |
Use of Ceftolozane/Tazobactam in the Treatment of Multidrug-resistant Pseudomonas aeruginosa Bloodstream Infection in a Pediatric Leukemia Patient.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Leukemia; Male; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2016 |
Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States Hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Cross Infection; Epidemiological Monitoring; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcal Skin Infections; United States | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
[An analysis of 181 cases with blood stream infection caused by Streptococcus agalactiae in children from 2011 to 2015: a multi-center retrospective study].
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cephalosporins; Child; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Penicillins; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae | 2016 |
Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Blood Culture; Cephalosporins; Child; Child, Preschool; Cloxacillin; Drug Resistance, Bacterial; Female; Ghana; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Thienamycins | 2016 |
Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Off-Label Use; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2017 |
Klebsiella pneumoniae bloodstream infections at a South African children's hospital 2006-2011, a cross-sectional study.
Topics: Bacteremia; beta-Lactamases; Cephalosporins; Child, Preschool; Community-Acquired Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; HIV Infections; Hospitals, Pediatric; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Retrospective Studies; Risk Factors; South Africa | 2016 |
Propensity score-matched analysis comparing the therapeutic efficacies of cefazolin and extended-spectrum cephalosporins as appropriate empirical therapy in adults with community-onset Escherichia coli, Klebsiella spp. and Proteus mirabilis bacteraemia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Community-Acquired Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Propensity Score; Proteus Infections; Proteus mirabilis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Kaplan-Meier Estimate; Male | 2017 |
Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Topics: Aged; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Endocarditis; Female; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2017 |
Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Topics: Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Salvage Therapy; Staphylococcal Infections; Vancomycin | 2017 |
Aspergillus Terreus Brain Abscess Complicated by Tension Pneumocephalus in a Patient with Angiosarcoma.
Topics: Aged; Anti-Bacterial Agents; Aspergillosis; Aspergillus; Bacteremia; Brain Abscess; Cefepime; Cephalosporins; Disease Progression; Drug Combinations; Drug Therapy, Combination; Glucocorticoids; Hemangiosarcoma; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Male; Pneumocephalus; Proteus mirabilis; Skin Neoplasms; Staphylococcus aureus; Sulfamethizole; Tomography, X-Ray Computed; Treatment Outcome; Trimethoprim; Vancomycin; Voriconazole | 2017 |
A propensity score-matched analysis of the impact of minimum inhibitory concentration on mortality in patients with Pseudomonas aeruginosa bacteremia treated with cefepime or ceftazidime.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Multivariate Analysis; Propensity Score; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Daptomycin; Female; Hospitalization; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Michigan; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salvage Therapy; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Infection in burn patients in a referral center in Colombia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Catheter-Related Infections; Central Venous Catheters; Cephalosporins; Child; Child, Preschool; Colombia; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Folliculitis; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Oxacillin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Wound Infection; Young Adult | 2017 |
Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftaroline; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Disk Diffusion Antimicrobial Tests; Humans; Oxacillin; Staphylococcus aureus | 2017 |
Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Drug Prescriptions; Hospitals; Humans; Methicillin Resistance; Organizational Policy; Prevalence; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia | 2008 |
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Cephalosporins; Child; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Young Adult | 2008 |
Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Neutropenia; Treatment Failure; Young Adult | 2009 |
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2009 |
[Utility of chromID ESBL medium for detection of cephalosporin-resistant enterobacteria in inoculated blood culture bottles].
Topics: Agar; Bacteremia; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Blood; Cephalosporin Resistance; Cephalosporins; Chromogenic Compounds; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; R Factors; Sensitivity and Specificity | 2009 |
Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Humans; Integrons; Italy; Male; Meropenem; Plasmids; Proteus Infections; Proteus mirabilis; Surgical Wound Infection; Thienamycins; Treatment Failure; Treatment Outcome | 2010 |
Chryseobacterium indologenes bacteremia in an infant.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Chryseobacterium; Female; Flavobacteriaceae Infections; Humans; Infant; Microbial Sensitivity Tests; Treatment Outcome | 2010 |
Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Horse Diseases; Horses; Immunoglobulin G; Injections, Intramuscular; Injections, Intravenous; Random Allocation; Sepsis; Treatment Outcome | 2009 |
Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Cephalosporin Resistance; Cephalosporins; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Hospitals, Veterans; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Taiwan; Treatment Outcome; Young Adult | 2009 |
Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2009 |
Clinical features, risk factors and outcomes of bacteremia due to enterococci with high-level gentamicin resistance: comparison with bacteremia due to enterococci without high-level gentamicin resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Neutropenia; Odds Ratio; Risk Factors; Severity of Illness Index; Treatment Outcome | 2010 |
Efficacy of cefepime therapy for Enterobacter bacteraemia, with special emphasis on febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Treatment Outcome | 2010 |
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Escherichia coli Infections; Fever; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Germany; Humans; Intensive Care Units; Population Surveillance; Practice Patterns, Physicians' | 2010 |
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mucositis; Pharynx; Risk Factors; Transplantation, Homologous; Vancomycin; Young Adult | 2010 |
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; Cephalosporins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; France; Genotype; Humans; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2011 |
The importance of pharmacokinetic consultation of cefepime treatment for Pseudomonas aeruginosa bacteremia: a case report of severe thermal burn injury.
Topics: Anti-Bacterial Agents; Bacteremia; Burns; Cefepime; Cephalosporins; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Europe; Female; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Treatment Outcome | 2011 |
A comparative study of three methods to evaluate an intervention to improve empirical antibiotic therapy for acute bacterial infections in hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Clostridioides difficile; Clostridium Infections; Drug Therapy; Fluoroquinolones; Guidelines as Topic; Hospitals; Humans; Incidence; Penicillin G; Staphylococcal Infections; Staphylococcus aureus; Sweden | 2011 |
Melioidosis presenting as sepsis syndrome: a case report.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Cefepime effectiveness in Gram-negative bloodstream infections.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States | 2011 |
Comamonas testosteroni infection in Taiwan: Reported two cases and literature review.
Topics: Aged; Alcoholism; Anti-Bacterial Agents; Bacteremia; Carcinoma, Hepatocellular; Cellulitis; Cephalosporins; Ciprofloxacin; Comamonas testosteroni; Gram-Negative Bacterial Infections; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Taiwan; Treatment Outcome | 2011 |
[Dental care of patients with organ transplants or prosthetic joints--a survey of specialty hospitals].
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacteremia; Cephalosporins; Clindamycin; Dental Care for Chronically Ill; Diagnosis, Oral; Endocarditis, Bacterial; Germany; Hospitals, Special; Humans; Oral Hygiene; Organ Transplantation; Penicillins; Periodontitis; Prosthesis-Related Infections; Risk Factors; Time Factors | 2011 |
Recurrent intravascular-catheter-related bacteremia caused by Delftia acidovorans in a hemodialysis patient.
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cephalosporins; Child; Delftia acidovorans; Female; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Renal Dialysis | 2011 |
Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Salvage Therapy; Staphylococcal Infections; Texas; Treatment Outcome | 2012 |
Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Male; Middle Aged; Multivariate Analysis; New Zealand; Retrospective Studies; Risk Factors | 2012 |
Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Female; Humans; Immunosuppressive Agents; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Rate; Young Adult | 2012 |
Cefepime for Gram-negative bacteremia in long-term hemodialysis: a single-center experience.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2012 |
Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies | 2012 |
Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Cohort Studies; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2012 |
The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Ceftaroline; Cephalosporins; Endocarditis, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Pneumonia, Staphylococcal; Prodrugs; Retrospective Studies; Staphylococcal Infections; Treatment Outcome | 2013 |
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2012 |
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2013 |
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests | 2013 |
Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Genotype; Hospitals, University; Humans; Infections; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Survival Analysis; Switzerland; Tertiary Care Centers; Treatment Outcome | 2013 |
Retrospective analysis of clinical and microbiological aspects of Klebsiella oxytoca bacteremia over a 10-year period.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2002 |
[Infective endocarditis with perivalvular abscess in a patient with Erysipelothrix rhusiopathiae bacteremia].
Topics: Abscess; Adult; Aortic Valve; Aortic Valve Insufficiency; Bacteremia; Ceftriaxone; Cephalosporins; Endocarditis, Bacterial; Erysipelothrix Infections; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Male | 2002 |
Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Topics: Adult; Aged; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2002 |
Update on prosthetic joints, dental treatment, and antibiotic prophylaxis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Bacteremia; Cefazolin; Cephalexin; Cephalosporins; Cephradine; Clindamycin; Clinical Protocols; Dental Care; Humans; Joint Prosthesis; Patient Care Planning; Penicillins; Practice Guidelines as Topic; Risk Factors | 2002 |
Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Incidence; Infant; Infant, Newborn; Korea; Length of Stay; Male; Middle Aged; Morbidity; Recurrence; Retrospective Studies; Risk Factors; Serratia Infections; Survival Rate | 2002 |
Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Colony Count, Microbial; Computer Simulation; Endotoxins; Female; Lipopolysaccharides; Microscopy, Phase-Contrast; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley | 2003 |
Management of aortic aneurysm infected with Salmonella.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ambulatory Care; Aneurysm, Infected; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Bacteremia; Ceftriaxone; Cephalosporins; Combined Modality Therapy; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Salmonella Infections | 2003 |
Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Citrobacter freundii; Confidence Intervals; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Probability; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Risk Factors; Streptococcus pneumoniae | 2004 |
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
Henoch-Schonlein purpura associated with Kingella kingae bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Humans; IgA Vasculitis; Infant; Kingella kingae; Male; Neisseriaceae Infections; Skin | 2004 |
Salmonella enterica serotype Choleraesuis infection in a medical center in northern Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Feces; Female; Fever; Focal Infection; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Salmonella enterica; Salmonella Infections; Taiwan; Wounds and Injuries | 2004 |
Underdiagnosis of urinary tract infection caused by Methylobacterium species with current standard processing of urine culture and its clinical implications.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child, Preschool; Colony Count, Microbial; Culture Media; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Methylobacterium; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Urine | 2004 |
[Spontaneous bacterial peritonitis].
Topics: Bacteremia; Bacterial Infections; Bacterial Translocation; Cephalosporins; Clinical Trials as Topic; Fluoroquinolones; Humans; Hypertension, Portal; Liver Cirrhosis; Meta-Analysis as Topic; Peritonitis; Risk Factors; Secondary Prevention | 2004 |
[Endocarditis due to the Neisseria elongata subspecies nitroreducens].
Topics: Aged; Amikacin; Aorta; Aortic Aneurysm; Aortic Valve; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Neisseria elongata; Neisseriaceae Infections; Species Specificity; Ultrasonography | 2004 |
Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacteremia; Case-Control Studies; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Korea; Male; Middle Aged; Risk Factors | 2005 |
Bacteremia among Kenyan Children.
Topics: Bacteremia; Cephalosporins; Ciprofloxacin; Fever of Unknown Origin; Ghana; Humans; Microbial Sensitivity Tests; Salmonella typhi | 2005 |
Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children.
Topics: Analysis of Variance; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Child; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Regression Analysis; Risk Factors | 2005 |
Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Treatment Failure | 2005 |
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Brazil; Carbapenems; Cephalosporins; Cohort Studies; Costs and Cost Analysis; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2006 |
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Culture Media; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2006 |
Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Hospitals, University; Humans; Israel; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Child; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Nepal; Paratyphoid Fever; Salmonella Infections; Salmonella paratyphi A; Salmonella typhimurium; Sentinel Surveillance | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2006 |
Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporins; Cohort Studies; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2006 |
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical | 2006 |
High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Infections; Catheterization; Cefepime; Cephalosporins; Drug Resistance; Equipment Contamination; Fever; Gentamicins; Hematologic Diseases; Hematologic Neoplasms; Hospitals, Urban; Humans; Laboratories, Hospital; Medical Audit; Microbial Sensitivity Tests; Neutropenia; New Zealand; Prospective Studies; Risk Assessment; Species Specificity | 2007 |
Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Topics: Aged; Bacteremia; Cephalosporins; Citrobacter freundii; Cohort Studies; Drug Resistance; Enterobacter; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Male; Middle Aged; Predictive Value of Tests; Respiration, Artificial; Retrospective Studies; Statistics as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Escherichia coli aortic valve endocarditis.
Topics: Aged; Anti-Bacterial Agents; Aortic Valve; Bacteremia; Cefepime; Cephalosporins; Echocardiography, Transesophageal; Endocarditis, Bacterial; Escherichia coli; Escherichia coli Infections; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Time Factors; Treatment Outcome | 2007 |
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors | 2007 |
Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
Topics: Adult; Aged; Analysis of Variance; Anti-Infective Agents; Bacteremia; Cephalosporins; Decision Support Techniques; Drug Resistance, Microbial; Emergency Service, Hospital; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; ROC Curve | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
Nontyphoidal Salmonella bacteremia in previously healthy children: analysis of 199 episodes.
Topics: Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Cephalosporins; Child, Preschool; Diarrhea; Female; Fever; Humans; Infant; Leukocytosis; Male; Meningitis; Osteomyelitis; Salmonella Infections; Taiwan | 2007 |
Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Survival Rate; Treatment Outcome | 2007 |
[Emergence of beta-lactam-dependent Bacillus cereus associated with prolonged treatment with cefepime in a neutropenic patient].
Topics: Adolescent; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus cereus; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Female; Humans; Microbial Sensitivity Tests; Neutropenia; Risk Factors | 2007 |
A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Cephalosporins; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Length of Stay; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2008 |
Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cefepime; Cephalosporins; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Retrospective Studies; Vancomycin; Victoria | 2008 |
New recommendations in the treatment of Gram-positive bacteraemia in dialysis patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Gram-Positive Bacterial Infections; Humans; Renal Dialysis; Thrombocytopenia; Vancomycin | 2008 |
[Yersinia enterocolitica septicemia, iron overload and deferoxamine].
Topics: Anemia, Sideroblastic; Bacteremia; Cephalosporins; Deferoxamine; Humans; Iron; Male; Middle Aged; Yersinia enterocolitica; Yersinia Infections | 1995 |
Cephalosporin vs penicillin.
Topics: Bacteremia; Cephalosporins; Dental Care for Chronically Ill; Health Knowledge, Attitudes, Practice; Humans; Penicillins; Premedication; Prosthesis-Related Infections; Staphylococcal Infections; Streptococcal Infections; Surveys and Questionnaires | 1994 |
Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Recurrence; Salmonella enteritidis; Salmonella Infections; Tuberculosis, Hepatic | 1995 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Penicillin- and penicillin-cephalosporin-resistant pneumococcal septicaemia.
Topics: Aged; Aged, 80 and over; Bacteremia; Cephalosporins; Female; Humans; Male; Middle Aged; Penicillin Resistance; Streptococcus pneumoniae | 1994 |
Antibiotic prophylaxis in cutaneous surgery.
Topics: Administration, Oral; Anti-Bacterial Agents; Attitude of Health Personnel; Bacteremia; Cephalosporins; Dermatologic Surgical Procedures; Dermatology; Endocarditis, Bacterial; Erythromycin; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Medical History Taking; Private Practice; Risk Factors; Skin Diseases, Infectious; Surgical Wound Infection | 1995 |
Antibiotic susceptibility of streptococci isolated from blood from neutropenic patients.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Neutropenia; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus; Vancomycin | 1994 |
Beta-lactam resistance among Escherichia coli and Klebsiella species blood culture isolates in Finnish hospitals. Finnish Study Group for Antimicrobial Resistance.
Topics: Bacteremia; beta-Lactam Resistance; Cefuroxime; Cephalosporins; Drug Utilization; Escherichia coli; Escherichia coli Infections; Finland; Humans; Klebsiella; Klebsiella Infections | 1994 |
Nosocomial epiglottitis associated with penicillin- and cephalosporin-resistant Streptococcus pneumoniae bacteremia.
Topics: Bacteremia; Cephalosporins; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Epiglottitis; Humans; Male; Penicillin Resistance; Pneumococcal Infections | 1994 |
Bloodstream infections after interventional procedures in the biliary tract.
Topics: Bacteremia; Bile; Biliary Tract; Cephalosporins; Cholangiography; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Premedication; Radiology, Interventional; Risk Factors | 1994 |
Severe Klebsiella infection as a cause of mortality in neonates in Harare, Zimbabwe: evidence from postmortem blood cultures.
Topics: Bacteremia; Cause of Death; Cephalosporins; Drug Resistance, Microbial; Female; Gentamicins; HIV Seropositivity; HIV-1; Humans; Infant, Newborn; Infant, Premature, Diseases; Klebsiella; Klebsiella Infections; Male; Penicillin Resistance; Penicillins; Zimbabwe | 1993 |
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors | 1993 |
In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.
Topics: Animals; Bacteremia; Bacteria; Bacterial Infections; Cephalosporins; Female; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pyelonephritis; Urinary Tract Infections | 1993 |
A virulent nonencapsulated Haemophilus influenzae.
Topics: Amoxicillin; Animals; Bacteremia; Bacterial Capsules; Blotting, Southern; Ceftriaxone; Cephalosporins; Child, Preschool; DNA, Bacterial; Enzyme-Linked Immunosorbent Assay; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Meningitis, Bacterial; Otitis Media; Penicillins; Phenotype; Polysaccharides, Bacterial; Rats; Rats, Sprague-Dawley; Virulence | 1996 |
[Septic lung caused by methicillin-resistant Staphylococcus epidermidis].
Topics: Anti-Bacterial Agents; Bacteremia; Cefotiam; Cephalosporins; Humans; Lung Diseases; Male; Methicillin Resistance; Middle Aged; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis | 1995 |
Extracorporeal membrane oxygenation for refractory shock in fulminant meningococcal sepsis.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Humans; Infant; Meningococcal Infections; Shock, Septic | 1996 |
Bordetella holmesii sepsis in an asplenic adolescent.
Topics: Bacteremia; Bordetella; Bordetella Infections; Ceftriaxone; Cephalosporins; Child; Humans; Immunocompromised Host; Male; Splenectomy; Thrombocythemia, Essential | 1995 |
Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Topics: Anemia, Sickle Cell; Bacteremia; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1995 |
In vitro and in vivo antibacterial activities of S-1090, a new oral cephalosporin.
Topics: Animals; Bacteremia; Bacteria; Bacterial Infections; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1995 |
Sepsis due to coryneform group A-4 in an immunocompromised host.
Topics: Actinomycetales; Actinomycetales Infections; Bacteremia; Catheters, Indwelling; Ceftriaxone; Cephalosporins; Humans; Immunocompromised Host; Male; Middle Aged; Sepsis | 1995 |
Meningitis and septicemia due to Neisseria cinerea.
Topics: Adolescent; Bacteremia; Cefotaxime; Cephalosporins; Humans; Male; Meningitis, Bacterial; Neisseria; Neisseriaceae Infections; Species Specificity; Tooth Avulsion; Virulence | 1995 |
Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Cephalothin; Cross Infection; Culture Media; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Gentamicins; Humans; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Risk Factors; Seafood; Seawater; Vibrio cholerae | 1996 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Cefsulodin; Cephalosporins; Combined Modality Therapy; Female; Flow Cytometry; Humans; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Neutropenia; Neutrophils; Phagocytosis; Pseudomonas Infections; Pyelonephritis | 1996 |
Experimental endogenous septicaemia caused by Klebsiella pneumoniae and Escherichia coli in mice.
Topics: Ampicillin; Animals; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Disease Models, Animal; Escherichia coli Infections; Fluorouracil; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Penicillins; Pseudomonas Infections; Survival Analysis | 1996 |
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1996 |
A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Leukocyte Count; Male; Neoplasms; Neutropenia; Neutrophils; Platelet Count; Treatment Outcome | 1996 |
[Bacteremic peritonitis caused by Aeromonas hydrophila in a woman with cirrhosis].
Topics: Aeromonas hydrophila; Bacteremia; Cefotaxime; Cephalosporins; Chronic Disease; Female; Gram-Negative Bacterial Infections; Humans; Liver Cirrhosis; Middle Aged; Peritonitis | 1996 |
Shigella sonnei meningitis.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Dysentery, Bacillary; Humans; Infant; Male; Meningitis, Bacterial; Shigella sonnei | 1996 |
[Bacteremia caused by Capnocytophaga sp: presentation of 2 cases, one with endocarditis. Review of the literature].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male | 1996 |
Development of Aeromonas hydrophila bacteremia in a patient recovering from cholera.
Topics: Adult; Aeromonas; Bacteremia; Ceftriaxone; Cephalosporins; Cholera; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Humans | 1996 |
Helicobacter cinaedi bacteremia associated with localized pain but not with cellulitis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cellulitis; Cephalosporins; Doxycycline; Drug Therapy, Combination; Helicobacter Infections; HIV Seropositivity; Humans; Leg; Magnetic Resonance Imaging; Male; Pain | 1996 |
Extraintestinal Clostridium difficile infections.
Topics: Adolescent; Aged; Anti-Bacterial Agents; Antitrichomonal Agents; Bacteremia; Ceftazidime; Cephalosporins; Clostridioides difficile; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Vancomycin; Wounds and Injuries | 1996 |
Escherichia vulneris as a cause of intravenous catheter-related bacteremia.
Topics: Bacteremia; Catheterization, Central Venous; Cefazolin; Cephalosporins; Crohn Disease; Enterobacteriaceae Infections; Equipment Contamination; Escherichia; Female; Humans; Middle Aged; Parenteral Nutrition, Total | 1996 |
Prevention of infection in children with acute leukaemia. No major difference between total and selective bowel decontamination.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carboxymethylcellulose Sodium; Cephaloridine; Cephalosporins; Child; Child, Preschool; Colistin; Drug Therapy, Combination; Food Handling; Gram-Negative Bacterial Infections; Humans; Infant; Intestines; Leukemia, Myeloid, Acute; Neomycin; Neutropenia; Pneumonia, Pneumocystis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Sterilization; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.
Topics: Adolescent; Adult; Aged; Bacteremia; beta-Lactamases; Case-Control Studies; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Plasmids | 1996 |
Kingella kingae occult bacteremia in a toddler.
Topics: Age Factors; Bacteremia; Cefuroxime; Cephalosporins; Child, Preschool; Female; Humans; Kingella kingae; Neisseriaceae Infections | 1996 |
Activity of cefepime against nosocomial blood culture isolates.
Topics: Bacteremia; Bacteria; Cefepime; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1995 |
Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Filgrastim; Gentamicins; Granulocyte Colony-Stimulating Factor; Humans; Male; Neutropenia; Platelet Aggregation Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Ticlopidine | 1996 |
Incidence and outcome of Yersinia enterocolitica infection in thalassemic patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; beta-Thalassemia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Yersinia enterocolitica; Yersinia Infections | 1995 |
Penicillin-resistant Aerococcus viridans bacteremia in a child receiving prophylaxis for sickle-cell disease.
Topics: Anemia, Sickle Cell; Bacteremia; Cephalexin; Cephalosporins; Female; Humans; Infant; Penicillin Resistance; Penicillins; Streptococcaceae | 1996 |
Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
Topics: Aged; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Practice Guidelines as Topic; Streptococcus pneumoniae | 1996 |
Recurrence of pneumococcal sepsis caused by an intermediately penicillin-resistant organism treated with loracarbef.
Topics: Bacteremia; Cephalosporins; Drug Resistance, Microbial; Humans; Infant; Male; Pneumococcal Infections; Recurrence | 1996 |
Bacteremia due to Citrobacter species: significance of primary intraabdominal infection.
Topics: Adolescent; Adult; Aged; Bacteremia; Cephalosporins; Child; Child, Preschool; Citrobacter; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae Infections; Female; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis | 1996 |
Risk factors for mortality associated with enterococcal bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; United States; Vancomycin | 1996 |
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.
Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Arteriosclerosis; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Mortality; Penicillins; Retrospective Studies; Salmonella; Salmonella Infections; Seroepidemiologic Studies; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Incidence of deep sepsis in uncemented total hip arthroplasty using clean air facility as a function of antibiotic prophylaxis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Cefamandole; Cephalosporins; Evaluation Studies as Topic; Female; Hip Prosthesis; Humans; Incidence; Male; Middle Aged; Prognosis; Prosthesis-Related Infections; Treatment Outcome | 1996 |
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins | 1996 |
Transient bacteremia after tooth extraction with intravenous cefuroxime prophylaxis.
Topics: Adult; Aged; Bacteremia; Cefuroxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Tooth Extraction | 1995 |
Infectious complications in left ventricular assist device recipients.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antifungal Agents; Antitrichomonal Agents; Aspergillus; Bacteremia; Bacterial Infections; Candida; Cephalosporins; Female; Fluoroquinolones; Glycopeptides; Gram-Negative Bacteria; Gram-Positive Bacteria; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Mycoses; Penicillins; Thienamycins | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Invasive infections caused by Yersinia enterocolitica in infants.
Topics: Arthritis, Infectious; Bacteremia; Cephalosporins; Female; Humans; Infant; Male; Meningitis, Aseptic; Yersinia enterocolitica; Yersinia Infections | 1997 |
Evaluation of a protocol for selective empiric treatment of fever without localising signs.
Topics: Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clinical Protocols; Emergency Service, Hospital; Evaluation Studies as Topic; Fever; Humans; Infant; Infant, Newborn; Leukocyte Count; Retrospective Studies | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Clinical efficacy of Cefuroxime axetil in S. typhi.
Topics: Bacteremia; Cefuroxime; Cephalosporins; Child; Female; Follow-Up Studies; Humans; Male; Prodrugs; Remission Induction; Salmonella typhi; Typhoid Fever | 1996 |
Mycoplasma in urine and blood following catheterisation of patients undergoing vascular surgery.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Bacteriuria; Cefuroxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoplasma hominis; Mycoplasma Infections; Prospective Studies; Ureaplasma urealyticum; Urinary Catheterization; Vascular Surgical Procedures | 1997 |
A critical role of tumor necrosis factor (TNF) alpha in experimental group A streptococcal (GAS) bacteremia.
Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftriaxone; Cephalosporins; Cytokines; Disease Models, Animal; Female; Humans; Lymphotoxin-alpha; Male; Papio; Streptococcal Infections; Streptococcus pyogenes | 1997 |
Relapsing infection due to Enterobacter species: lessons of heterogeneity.
Topics: Abscess; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Mutation; Pneumonia, Bacterial | 1997 |
Total knee arthroplasty infections associated with dental procedures.
Topics: Aged; Antibiotic Prophylaxis; Arthritis, Rheumatoid; Arthroplasty, Replacement, Knee; Bacteremia; Cephalosporins; Dental Care; Diabetes Mellitus, Type 1; Disease Susceptibility; Female; Gingival Neoplasms; Humans; Male; Middle Aged; Periodontal Abscess; Periodontal Diseases; Postoperative Care; Premedication; Prosthesis-Related Infections; Referral and Consultation; Retrospective Studies; Risk Factors; Root Canal Therapy; Sepsis; Time Factors; Tooth Extraction; Treatment Outcome | 1997 |
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial | 1997 |
Acute pansinusitis with bacteremia due to a beta-hemolytic group C streptococcus: Streptococcus milleri.
Topics: Acute Disease; Adult; Bacteremia; Cefazolin; Cephalosporins; Debridement; Drainage; Humans; Male; Paranasal Sinuses; Sinusitis; Streptococcal Infections; Streptococcus | 1997 |
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteremia; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Fungemia; Humans; Neoplasms; Ofloxacin | 1997 |
Meningococcal meningitis during penicillin therapy for meningococcemia.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Child; Female; Humans; Meningitis, Meningococcal; Penicillin Resistance; Penicillins | 1997 |
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Erythromycin; Humans; Penicillins; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
Topics: Bacteremia; Cefotaxime; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple; Humans; Infant; Infusions, Intravenous; Male; Meningitis, Pneumococcal; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
Cephalosporin vs penicillin.
Topics: Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Dental Care; Drug Utilization; Humans; Joint Prosthesis; Orthopedics; Penicillins; Prosthesis-Related Infections; San Francisco; Surveys and Questionnaires | 1995 |
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome.
Topics: Aged; Bacteremia; Ceftazidime; Cephalosporins; Female; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Pneumonia, Bacterial; Thienamycins; Treatment Outcome | 1998 |
Intraperitoneal abscess in a new born secondary to Klebsiella septicaemia--a case report.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Peritoneal Cavity | 1998 |
Antibiotic cover following joint replacement.
Topics: Antibiotic Prophylaxis; Arthroplasty, Replacement; Bacteremia; Cephalosporins; Dental Care; Humans; Risk Factors | 1998 |
Prospective study of bacteraemia in cancer patients. Results of a French multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacteria; Bacteriological Techniques; Cefepime; Cefpirome; Ceftazidime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Opportunistic Infections; Prospective Studies | 1998 |
Congenital endophthalmitis following maternal shellfish ingestion.
Topics: Animals; Bacteremia; Cefotaxime; Cephalosporins; Cyclopentolate; Endophthalmitis; Eye Infections, Bacterial; Female; Food Microbiology; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Meningitis, Bacterial; Mydriatics; Ostreidae; Plesiomonas; Pregnancy; Pregnancy Complications, Infectious | 1998 |
Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin.
Topics: Ambulatory Care; Anti-Bacterial Agents; Bacteremia; Cefazolin; Cephalosporins; Drug Therapy, Combination; Enterococcus; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Metabolic Clearance Rate; Methicillin Resistance; Microbial Sensitivity Tests; Renal Dialysis; Staphylococcus; Vancomycin; Wound Infection | 1998 |
[Cutaneous manifestations of erysipeloid septicemia].
Topics: Animals; Bacteremia; Bites and Stings; Ceftriaxone; Cephalosporins; Ducks; Erysipeloid; Humans; Male; Middle Aged; Skin Diseases, Infectious | 1998 |
Inducible beta-lactam resistance in Aeromonas hydrophila: therapeutic challenge for antimicrobial therapy.
Topics: Aeromonas hydrophila; Bacteremia; Base Sequence; beta-Lactamases; Burns; Cephalosporin Resistance; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Gram-Negative Bacterial Infections; Humans; Middle Aged; Mutation; Polymerase Chain Reaction; Surgical Wound Infection | 1998 |
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime.
Topics: Bacteremia; Cefepime; Cephalosporins; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Clinical implications of penicillin and ceftriaxone resistance among children with pneumococcal bacteremia.
Topics: Adolescent; Adult; Bacteremia; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 1999 |
[Salmonellosis in HIV infection in a hospital setting in Gabon].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Female; Fluoroquinolones; Focal Infection; Follow-Up Studies; Gabon; HIV Infections; HIV Seronegativity; Humans; Incidence; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Serotyping; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Moraxella catarrhalis pneumonia and bacteremia in an otherwise healthy child.
Topics: Bacteremia; Ceftriaxone; Cephalosporins; Female; Humans; Infant; Moraxella catarrhalis; Pneumonia, Bacterial | 1999 |
Infectibility of endovascular stents following antibiotic prophylaxis or after arterial wall incorporation.
Topics: Angioplasty; Animals; Antibiotic Prophylaxis; Bacteremia; Blood Vessel Prosthesis Implantation; Cefazolin; Cephalosporins; Female; Iliac Artery; Staphylococcal Infections; Stents; Swine; Time Factors | 1999 |
Bacteremia with CDC group IV c-2 in an immunocompetent infant.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Infant | 1999 |
Bacteremia in the infant with bronchiolitis.
Topics: Acute Disease; Albuterol; Bacteremia; Bronchiolitis; Bronchodilator Agents; Ceftriaxone; Cephalosporins; Diagnosis, Differential; Humans; Infant; Male; Pneumococcal Infections | 1999 |
Fulminant necrotising fasciitis caused by Vibrio parahaemolyticus.
Topics: Aged; Animals; Anti-Bacterial Agents; Bacteremia; Brachyura; Ceftazidime; Cephalosporins; Debridement; Doxycycline; Drug Therapy, Combination; Fasciitis, Necrotizing; Humans; Male; Seawater; Vibrio Infections; Vibrio parahaemolyticus | 1999 |
Ischaemic hepatitis in an elderly woman.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Bacteremia; Ceftriaxone; Cephalosporins; Female; Hepatitis; Humans; Ischemia; L-Lactate Dehydrogenase; Liver; Sepsis; Staphylococcal Infections | 1999 |
Gonococcal bacteremia in a neonate.
Topics: Adult; Bacteremia; Cefotaxime; Cephalosporins; Female; Gonorrhea; Humans; Infant, Newborn; Neisseria gonorrhoeae; Pregnancy; Pregnancy Complications, Infectious; Synovitis; Treatment Outcome | 2000 |
[Bacteremia and Pasteurella multocida pneumonia revealing HIV infection].
Topics: Adult; Amoxicillin; Animals; Anti-Infective Agents; Bacteremia; Bites and Stings; Cats; Cefotaxime; Cephalosporins; HIV Infections; HIV Seropositivity; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pefloxacin; Penicillins; Pneumonia, Bacterial; Time Factors | 1999 |
Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Fever; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Treatment Outcome | 2000 |
Beware of short-course therapy for Staphylococcus aureus bacteremia without a removable cause.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Cefazolin; Cephalosporins; Clavulanic Acids; Discitis; Drug Therapy, Combination; Enzyme Inhibitors; Epidural Abscess; Follow-Up Studies; Foot Diseases; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Ticarcillin; Vancomycin | 2000 |
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Topics: Adolescent; Adult; Aeromonas; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Prognosis; Risk Factors | 2000 |
Back pain in an elderly man--more than just a fall.
Topics: Accidental Falls; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Back Pain; Bacteremia; Ceftriaxone; Cephalosporins; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Humans; Lumbar Vertebrae; Male; Penicillins | 2000 |
Bacteremia and possible endocarditis caused by Moraxella phenylpyruvica.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Male; Moraxella; Neisseriaceae Infections; Ofloxacin; Penicillins | 2000 |
Extra-intestinal non-typhoidal Salmonella infections in children.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Retrospective Studies; Salmonella enteritidis; Salmonella Infections; Salmonella paratyphi B; Salmonella typhimurium; Serotyping; Treatment Outcome | 2000 |
[Bacteremia caused by Enterobacter cloacae: emergence of antibiotic resistance after antibiotic prophylaxis].
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aortic Aneurysm, Abdominal; Bacteremia; Cefamandole; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Pneumonia, Bacterial; Postoperative Complications | 2000 |
When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Topics: Amphotericin B; Analysis of Variance; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Candida; Candida albicans; Candidiasis; Catheterization, Central Venous; Cephalosporins; Cross Infection; Diagnosis, Differential; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Logistic Models; Retrospective Studies; Risk Factors; Staphylococcal Infections | 2000 |
Imipenem therapy for septicemic melioidosis in a child with penicillin and cephalosporin adverse reaction.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Cephalosporins; Child; Diabetes Complications; Drug Therapy, Combination; Humans; Imipenem; Male; Melioidosis; Thienamycins | 2000 |
[Hafnia alvei septicemia revealing pyocholecystitis complicated by liver abscess in an immunocompetent patient].
Topics: Acute Disease; Aged; Bacteremia; Cefepime; Cephalosporins; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; Cholecystitis; Enterobacteriaceae Infections; Gentamicins; Hafnia alvei; Humans; Liver Abscess; Male; Netilmicin; Suppuration; Treatment Outcome | 2000 |
High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Cephalosporin Resistance; Cephalosporins; Female; Gene Frequency; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Streptococcal Infections; Streptococcus | 2001 |
Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Plasmids | 2001 |
Prediction of gram-negative bacteremia in patients with cancer and febrile neutropenia by means of interleukin-8 levels in serum: targeting empirical monotherapy versus combination therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Drug Therapy, Combination; Fever; Gentamicins; Gram-Negative Bacterial Infections; Humans; Interleukin-8; Leukemia; Lymphoma; Male; Middle Aged; Netilmicin; Neutropenia; Predictive Value of Tests; Prospective Studies | 2001 |
Non-serogroup O:1 Vibrio cholerae bacteremia and cerebritis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Cholera; Ciprofloxacin; Humans; Male; Meningitis, Bacterial; Vibrio cholerae | 2001 |
Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans.
Topics: Bacteremia; Bacteriological Techniques; Borrelia burgdorferi Group; Cefuroxime; Cephalosporins; Child; Child, Preschool; Erythema Chronicum Migrans; Female; Humans; Infant; Male; Penicillin V; Penicillins; Prospective Studies; Treatment Outcome | 2001 |
Case-control study of risk factors for the development of enterococcal bacteremia.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Catheters, Indwelling; Cephalosporins; Cross Infection; Enterococcus; Female; Humans; Imipenem; Incidence; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prospective Studies; Risk Factors; Statistics, Nonparametric; Thienamycins | 2001 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Health Policy; Humans; Risk Factors; Slovakia | 2001 |
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Humans; Infant; Pneumococcal Infections; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae | 2001 |
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
Topics: Bacteremia; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Drug Utilization; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Risk Factors | 2001 |
Case report: recovery from persistent septicemic melioidosis.
Topics: Adult; Bacteremia; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Melioidosis; Meropenem; Spleen; Thienamycins; Western Australia | 2001 |
Lipopolyamines as a therapeutic strategy in experimental Gram-negative bacterial sepsis.
Topics: Animals; Bacteremia; Ceftazidime; Cephalosporins; Disease Models, Animal; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Gram-Negative Bacterial Infections; Neutropenia; Rats; Sepsis; Survival Analysis | 2001 |
Invasive group A streptococcus in two siblings: a case for antibiotic prophylaxis of close contacts.
Topics: Antibiotic Prophylaxis; Arthritis, Infectious; Bacteremia; Canada; Cephalexin; Cephalosporins; Child; Child, Preschool; Female; Humans; Male; Nuclear Family; Spouses; Streptococcal Infections; Streptococcus pyogenes | 2001 |
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models | 2001 |
Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.
Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Isoelectric Point; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Treatment Outcome | 2002 |
Streptococcus pneumoniae resistance to penicillin and ceftriaxone in a tertiary care center in Saudi Arabia.
Topics: Adolescent; Bacteremia; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male; Penicillins; Retrospective Studies; Saudi Arabia; Streptococcal Infections; Streptococcus pneumoniae | 2002 |
Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia.
Topics: Adult; Aged; Aminoglycosides; Bacteremia; Cephalosporins; Citrobacter freundii; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
[Non-typhic Salmonella bacteremias in HIV infections. Clinical and therapeutic data, and course in 68 patients].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Cephalosporins; Drug Therapy, Combination; Female; HIV Infections; Humans; In Vitro Techniques; Male; Opportunistic Infections; Penicillins; Retrospective Studies; Salmonella; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium; Zidovudine | 1992 |
Dual-action penems.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross-Linking Reagents; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Quinolinium Compounds | 1992 |
The incidence and beta-lactam resistance of Proteus vulgaris in hospital infections: the last decade.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Aztreonam; Bacteremia; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Phenotype; Proteus Infections; Proteus vulgaris; Spain; Urinary Tract Infections | 1991 |